SlideShare a Scribd company logo
1 of 16
Download to read offline
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2022-23) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 1 of 16 
ACECLOFENAC  RBPL-A0100 89796-99-6 C16H13Cl2NO4; 354.18
Aceclofenac Impurity A (Diclofenac Free Acid)
(Diclofemac Sodium) (Diclofenac Impurity K)
RBPL-A0101
15307-86-5 (Free acid);
15307-79-6(Na)
15307-81-0(K)
C14H10Cl2NNaO2; 318.13
C14H11Cl2NO2
296.14 (FA)
Aceclofenac Impurity B (Diclofenac Methyl Ester) RBPL-A0102 15307-78-5; C15H13Cl2NO2; 310.18
Aceclofenac Impurity I
(Aceclofenac Related Compound A)
(Diclofenac Amide) (Diclofenac Impurity A)
(Diclofenac Related Compound A)
(Diclofenac Lactum Impurity)
RBPL-A0103 15362-40-0 C14H9Cl2NO; 278.13
Aceclofenac Impurity E (Aceclofenac Ethyl Ester) RBPL-A0104 139272-67-6 C18H17Cl2NO4; 382.24
Aceclofenac Impurity D (Aceclofenac Methyl Ester) RBPL-A0105 139272-66-5; C17H15Cl2NO4; 368.21
Aceclofenac Impurity F (Aceclofenac Benzyl Ester) RBPL-A0106 100499-89-6 C23H19Cl2NO4; 444.31
Aceclofenac Impurity G RBPL-A0107 1215709-75-3 C18H15Cl2NO6; 412.22
AZITHROMYCIN RBPL-A0200 83905-01-5 C38H72N2O12, 748.98
Azithromycin Impurity E RBPL-A0201 612069-27-9 C36H68N2O12; 720.93
Azithromycin Impurity F (Azithromycin Related Compound F) RBPL-A0202 612069-28-0 C38H70N2O13; 762.97
Azithromycin Impurity I RBPL-A0203 172617-84-4 C37H70N2O12; 734.96
Azithromycin Impurity L (Azithromycin N-oxide) RBPL-A0204 90503-06-3 C38H72N2O13; 764.98
Azithromycin Impurity M RBPL-A0206 765927-71-7 C37H68N2O13; 748.94
Azithromycin Impurity N RBPL-A0207 612069-25-7 C₃₆H₆₅NO₁₃; 719.9
Azithromycin Impurity A (Azaerythromycin )
(Azithromycin Related Compound A)
RBPL-A0208 76801-85-9 C37H70N2O12; 734.96
Azithromycin Impurity J (Desosaminyl azithromycin) RBPL-A0209 117693-41-1 C30H58N2O9; 590.79
Azithromycin Impurity S (Clarithromycin Impurity J)
(Erythromycin-9-oxime) (Roxithromycin Impurity C)
RBPL-A02 13127-18-9 C₃₇H₆₈N₂O₁₃; 748.94
ALBENDAZOLE RBPL-A0300 54965-21-8 C12H15N3O2S 265.33
Albendazole Impurity C (Albendazole Sulphone) RBPL-A0301 75184-71-3 C12H15N3O4S; 297.33
Albendazole Impurity B (Albendazole S-oxide) RBPL-A0302 54029-12-8 C12H15N3O3S; 281.33
Albendazole Impurity D (Amino Albendazole Sulfone) RBPL-A0303 80983-34-2 C10H13N3O2S; 239.29
Albendazole Impurity A (Amino Albendazole) RBPL-A0305 80983-36-4 C10H13N3S; 207.3
ACEBUTOLOL RBPL-A0400 37517-30-9 C18H28N2O4; 336.42
Acebutolol Impurity C (Acebutolol Related Compound A) RBPL-A0401 40188-45-2 C12H15NO3; 221.25
Acebutolol Impurity J RBPL-A0402 57898-79-0 C17H27ClN2O4; 358.
AZELASTINE RBPL-A0500 58581-89-8 C22H24ClN3O, 381.90
Azelastine Impurity A RBPL-A0501 613-94-5 C7H8N2O; 136.15
ABIRATERONE ACETATE RBPL-A0600 154229-18-2 C26H33NO2; 391.55
Abiraterone RBPL-A0603 154229-19-3 C₂₄H₃₁NO; 349.51
3-Keto Abiraterone RBPL-A0604 154229-21-7 C24H29NO; 347.49
Abiraterone N, N-dioxide RBPL-A0605 2378463-76-2 C24H31NO2; 365.5
ATORVASTATIN RBPL-A0800
Free Acid: 134523-00-5
134523-03-8
C₆₆H₆₈CaF₂N₄O₁₀; 1155.34
Atorvastatin Impurity H (Atorvastatin Lactone)
(Atorvastatin Related Compound H)
RBPL-A0801 125995-03-1 C33H33FN2O4; 540.62
o-OH Atorvastatin lactone RBPL-A0802 163217-74-1 C₃₃H₃₃FN₂O₅; 556.62
p-OH Atorvastatin lactone RBPL-A0803 163217-70-7 C₃₃H₃₃FN₂O₅; 556.62
Atovastatin Impurity D (Atorvastatin Related Compound D) RBPL-A0804 148146-51-4 C26H22FNO4; 431.46
Atovastatin Impuity C (Atorvastatin Related Compound C)
(Difluoro Atorvastatin)
RBPL-A0805
693793-53-2(ca salt);
693794-20-6 (FB)
C66H68CaF2N4O10; 1191.3;
C33H34F2N2O5; 576.63
Atovastatin Impurity A (Atorvastatin Related Compound A)
(Desfluoro Atorvastatin)
RBPL-A0806
433289-83-9
(Calcium salt)
C33H35CaN2O5+; 579.7194
Atovastatin Impurity B (Atorvastatin Related Compound B) RBPL-A0807 N/A C33H34N2O51/2Ca; 557.63
Atovastatin Related Compound E RBPL-A0808 501121-34-2 (free acid) C33H34N2NaO5; 557.63
Atorvastatin Methyl Ester RBPL-A0810 345891-62-5 C34H37FN2O5; 572.67
ASPIRIN RBPL-A0900 50-78-2 C₉H₈O₄; 180.16
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 2 of 16 
 
Aspirin Impurity E RBPL-A0901 552-94-3 C14H10O5; 258.23
Aspirin Impurity F RBPL-A0902 1466-82-6 C18H14O7; 342.3
Aspirin Impurity C RBPL-A0905 69-72-7 C₇H₆O₃; 138.12
AMOXICILLIN RBPL-A1000 26787-78-0 C16H19N3O5S; 365.40
Amoxicillin Impurity A (Amoxicillin Related Compound A) RBPL-A1001 551-16-6 C8H12N2O3S; 216.26
ARIPIPRAZOLE RBPL-A1100 129722-12-9 C23H27Cl2N3O2; 448.39
Aripiprazole Related Compound F (Aripiprazole N-oxide) RBPL-A1101 573691-09-5 C₂₃H₂₇Cl₂N₃O₃; 464.38
Aripiprazole-N,N'-dioxide RBPL-A1102 573691-13-1 C₂₃H₂₇Cl₂N₃O₄; 480.38
Aripiprazole Impurity A (Aripiprazole Related Compound A) RBPL-A1103 22246-18-0 C₉H₉NO₂; 163.17
ACETAZOLAMIDE RBPL-A1200 59-66-5 C4H6N4O3S2; 222.25
Acetazolamide Impurity A RBPL-A1201 60320-32-3 C₄H₄ClN₃OS; 177.61
Acetazolamide Impurity B RBPL-A1202 5393-55-2 C4H5N3OS; 143.17
Acetazolamide Impurity E RBPL-A1203 827026-60-8 (free acid) C4H5N3O4S2; 223.23
Acetazolamide Impurity C RBPL-A1204 32873-56-6 C₄H₅N₃OS₂; 175.23
AMLODIPINE RBPL-A1300 88150-42-9 C20H25ClN2O5; 408.88
Amlodipine Impurity A (Amlodipine Phthalimide) RBPL-A1301 88150-62-3 C₂₈H₂₇ClN₂O₇ ; 538.98
Amlodipine Impurity G RBPL-A1302 43067-01-2 C₁₇H₁₈ClNO₄; 335.78
Amlodipine Impurity E (Amlodipine Related Compound E) RBPL-A1303 140171-65-9 C₂₁H₂₇ClN₂O₅; 422.9
Amlodipine Besylate Related Compound A (Amlodipine
Impurity D)
RBPL-A1304
2138811-33-1(FB)
113994-41-5
C20H23ClN2O5. C4H4O4 ; 522.93
406.86
ALFUZOSIN RBPL-A1400 81403-80-7 C19H27N5O4, 389.45
Alfuzosin Impurity A RBPL-A1401
98902-29-5;
98902-36-4 (Base)
C₁₉H₂₄ClN₅O₄; 421.88
ALLOPURINOL RBPL-A1500 315-30-0 C5H4N4O; 136.11
Allopurinol Impurity A RBPL-A1501 27511-79-1 C4H6N4O; 126.12
Allopurinol Impurity D (Allopurinol Related Compound D) RBPL-A1502 6994-25-8 C6H9N3O2; 155.15
ACICLOVIR RBPL-A1600 59277-89-3 C8H11N5O3; 225.20
Aciclovir Impurity I RBPL-A1603 1797832-75-7 C14H16N10O4 ; 388.35
ASENAPINE RBPL-A2000 65576-45-6 C₁₇H₁₆ClNO; 285.77
Asenapine Amide RBPL-A2001 NA C17H14ClNO2; 299.75
Asenapine Deschloro RBPL-A2002 NA C17H17NO; 251.33
Cis-Asenapine RBPL-A2003 65621-78-5 C17H16ClNO; 285.77
Asenapine-N-oxide RBPL-A2004 128949-51-9 C17H16ClNO2; 301.77
Asenapine N-Desmethyl RBPL-A2005 1170701-78-6 C16H15Cl2NO; 308.20
Asenapine Deschloro amide RBPL-A2006 NA C17H17NO; 251.33
AMIODARONE RBPL-A2100 1951-25-3 C₂₅H₂₉I₂NO₃645.31
Amiodarone N-Oxide (HCl) RBPL-A2101 318267-30-0 C25H29I2NO4 ; 661.30
Amiodarone Impurity B (Amiodarone Related Compound B)
(Desethyl Amiodarone)
RBPL-A2102
96027-74-6 (Hcl);
freebase: 83409-32-9
C₂₃H₂₆ClI₂NO₃ ; 653.72
AMITRIPTYLINE RBPL-A2200 549-18-8 C20H24ClN; 313.9
Amitriptyline (Nortriptyline Impurity F) RBPL-A2200 50-48-6 (FB) C20H23N; 277.4
Amitriptyline N-Oxide (Nortriptyline Hydrochloride - Impurity J) RBPL-A2201 4317-14-0 C₂₀H₂₃NO ; 293.40
AMISULPRIDE RBPL-A2300 53583-79-2 C17H26N2O4S; 354.47
Amisulpride Impurity F (Amisulpride N-Oxide) RBPL-A2301 71676-01-2 C17H27N3O5S; 385.49
AFATINIB RBPL-A3200 439081-18-2 C₂₄H₂₅ClFN₅O₃; 485.94
Afatinib N-Oxide (Afatinib Impurity L) RBPL-A3201 NA C₂₄H₂₅ClFN₅O₄; 501.94
ATENOLOL RBPL-A3300 29122-68-7 C14H22N2O3; 266.34
ASPARTAME RBPL-A3500 22839-47-0 C14H18N2O5; 294.31
Aspartame Impurity B RBPL-A3501 13433-09-5 C13H16N2O5; 280.28
Aspartame Impurity C RBPL-A3502 63-91-2 C9H11NO2; 165.19
AMODIAQUINE HYDROCHLORIDE RBPL-A3900 6398-98-7 C20H22ClN3O·2HCl·2H2O; 464.81
BECLOMETHASONE RBPL-B0100 4419-39-0 C22H29ClO5, 408.92
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 3 of 16 
 
Beclomethasone Impurity R (Beclomethasone Dipropionate
Impurity R)
RBPL-B0101 NA C22H28O5; 372.47
Beclomethasone Impurity G RBPL-B0102 1186048-33-8 C31H41FO8; 560.65
Beclomethasone Impurity V RBPL-B0103 205105-83-5 C25H32O6; 428.52
BETAXOLOL RBPL-B0200 63659-18-7 C18H29NO3 · HCl; 343.89.
Betaxolol HCl Impurity A RBPL-B0201 464877-45-0 C14H24ClNO2; 273.8; 237 (FB)
Betaxolol HCl Impurity B RBPL-B0202 62572-94-5 C₁₄H₂₃NO₃; 253.34
BENDROFLUMETHIAZIDE RBPL-B0400 73-48-3 C15H14F3N3O4S2, 421.41
Bendroflumethiazide Impurity A RBPL-B0401 654-62-6 C₇H₈F₃N₃O₄S₂; 318.28
BRIMONIDINE RBPL-B0500
59803-98-4
Tartrate Salt: 59803-99-5
C₁₁H₁₀BrN₅; 292.13
Brimonidine Impurity A RBPL-B0501 91147-43-2 C11H11N5; 213.24
BORTEZOMIB RBPL-B0800 179324-69-7 C19H25BN4O4 384.24
Bortezomib Impurity B RBPL-B0801 114457-94-2 C₁₄H₁₃N₃O₃; 271.27
BENZOTHIADIAZINE RBPL-B1000 255-18-5 C7H6N2S; 150.2
Benzothiadiazine Related Compound A RBPL-B1001 121-30-2 C₆H₈ClN₃O₄S₂; 285.73
BIPERIDEN RBPL-B1200 514-65-8 C21H29NO; 311.4611
Biperiden N-Oxide (Lidocaine Impurity B) RBPL-B1201 2903-45-9 C₁₄H₂₂N₂O₂; 250.34
BROMHEXINE Hcl RBPL-B1400 611-75-6 (Hcl) C14H20Br2N2 · HCl; 412.59
Bromhexine N-oxide RBPL-B1401 NA C14H20Br2N2O; 392.14
BISACODYL RBPL-B1700 603-50-9 C22H19NO4; 361.391
CLARITHROMYCIN RBPL-C0100 81103-11-9 C38H69NO13; 747.95
14-Hydroxy Clarithromycin RBPL-C0101 116836-41-0 C38H69NO14; 763.95
Clarithromycin Impurity D (Clarithromycin Related Compound
D) (N-Desmethyl Clarithromycin)
RBPL-C0102 101666-68-6 C37H67NO13; 733.93
Clarithromycin Impurity Q (Clarithromycin N-oxide)
(Clarithromycin Related Compound Q)
RBPL-C0103 118074-07-0 C38H69NO14; 763.95
Clarithromycin Impurity I RBPL-C0104 118058-74-5 C30H55NO10; 589.76
Clarithromycin Impurity K RBPL-C0105 127157-35-1 C30H51NO8; 553.73
Clarithromycin Impurity L (Clarithromycin (9Z)-Oxime) RBPL-C0106 127253-05-8 C38H70N2O13; 762.97
Clarithromycin Impurity M RBPL-C0107 127182-43-8 C37H68N2O13; 748
Clarithromycin Impurity N RBPL-C0108 144604-03-5 C38H67NO12; 729.94
Clarithromycin Impurity C
(Clarithromycin E-9-Oxime)
RBPL-C0109 127253-06-9 C38H70N2O13; 762.97
Clarithromycin Impurity E (Related Compound A) RBPL-C0110 81103-14-2 C39H71NO13; 761.98
Clarithromycin Impurity J (Erythromycin-9-oxime)
(Roxithromycin Impurity C) (Azithromycin Impurity S)
RBPL-C0112 13127-18-9 C₃₇H₆₈N₂O₁₃; 748.94
Clarithromycin Impurity R RBPL-C0113 992-62-1 C36H65NO13; 719.9
CAPECITABINE RBPL-C0200 154361-50-9 C15H22FN3O6; 359.35
Capecitabine Related Compound C RBPL-C0201 921769-65-5 C₁₆H₂₀FN₃O₇; 385.34
CITALOPRAM RBPL-C0300 59729-33-8 C20H21FN2O; 324.392
Citalopram Hydrobromide RBPL-C0300 59729-32-7 C20H21FN2O·HBr; 405.31
Citalopram Impurity D RBPL-C0301 1188264-72-3 C19H20BrFN2O; 391.28
Citalopram N-oxide (Citalopram Related Compound E) RBPL-C0302 63284-72-0 C20H21FN2O2; 340.3913
Citalopram Impurity C (Citalopram Related Compound C) RBPL-C0303 372941-54-3 C₂₀H₁₉FN₂O₂; 338.38
Citalopram Impurity E RBPL-C0304 NA C19H22BrClFNO; 413.05
Citalopram Impurity G RBPL-C0305 1329745-98-3 (FB) C25H33FN2O2; 412.54
CLOPIDOGREL RBPL-C0400 113665-84-2 C16H16ClNO2S, 321.82
Clopidogrel Impurity A (Clopidogrel Related Compound A) RBPL-C0401 144750-42-5 (Hcl) C15H15Cl2NO2S; 344.26
Clopidogrel Impurity B (Clopidogrel Related Compound B) RBPL-C0402 144750-52-7 C₁₆H₁₇Cl₂NO₂S; 358.28
Clopidogrel Impurity C (Clopidogrel Related Compound C) RBPL-C0403 120202-71-3 C₁₆H₁₈ClNO₆S₂; 419.9
COLCHICINE RBPL-C0500 64-86-8 C22H25NO6; 399.44
Colchicine Impurity E RBPL-C0501 7336-33-6 C₂₁H₂₃NO₆; 385.41
Colchicine Impurity A RBPL-C0502 7411-12-3 C₂₁H₂₃NO₆; 385.41
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 4 of 16 
 
Colchicine Impurity D (Colchicoside) RBPL-C0503 477-29-2 C27H33NO11; 547.55
CLOMIPRAMINE RBPL-C0700 303-49-1 C19H23ClN2; 314.85
Clomipiramine Impurity G RBPL-C0701 1425793-87-8 C17H16ClN; 269.77
Clomipiramine N-Oxide RBPL-C0705 14171-67-6 C19H23ClN2O; 330.85
CLOZAPINE RBPL-C0800 5786-21-0 C18H19ClN4 326.83
Clozapine Impurity D RBPL-C0801 65514-71-8 C18H21ClN4O; 344.84
Clozapine-N-oxide RBPL-C0802 34233-69-7 C18H19ClN4O; 342.82
CARVEDILOL RBPL-C1000 72956-09-3 C24H26N2O4 406.48
Carvedilol Impurity A (Carvedilol Related Compound A) RBPL-C1001 1076199-79-5 C₃₆H₄₃N₃O₇; 629.74
Carvedilol Impurity C (Carvedilol Related Compound C) RBPL-C1002 72955-94-3 C31H32N2O4 ; 496.6
CETIRIZINE RBPL-C1100 83881-51-0 C21H25ClN2O3; 388.89
Cetirizine -N-oxide RBPL-C1101 1076199-80-8 C21H25ClN2O4; 404.8
Cetirizine Impurity A (Hydroxyzine Related Compound A) RBPL-C1102 303-26-4 C₁₇H₁₉ClN₂; 286.8
CLOTRIMAZOLE RBPL-C1200 23593-75-1 C22H17ClN2 344.84
Clotrimazole Impurity E RBPL-C1201 5162-03-8 C₁₃H₉ClO; 216.66
CYCLOPHOSPHAMIDE RBPL-C1300 50-18-0 C7H15Cl2N2O2P; 261.09
Cyclophosphamide Related Compound A RBPL-C1301
821-48-7 (HCl)
334-22-5 (FB)
C₄H₁₀Cl₃N; 178.49
CELECOXIB RBPL-C1400 169590-42-5 C17H14F3N3O2S; 381.37
Celecoxib Impurity A (Celecoxib Related Compound A) RBPL-C1401 170570-01-1 C17H14F3N3O2S; 381.38
CIPROFLOXACIN RBPL-C1500 85721-33-1 C17H18FN3O3; 331.34
Ciprofloxacin Impurity F (Ciprofloxacin 6-Hydroxy Analog) RBPL-C1501 226903-07-7 C17H19N3O4; 329.35
CHLORPROMAZINE RBPL- C1700 50-53-3 C17H19ClN2S; 318.86
Chlorpromazine N-oxide| RBPL-C1702 1672-76-0 C17H19ClN2OS; 334.86
Chlorpromazine Impurity C RBPL-C1705
53-60-1 (HCl)
58-40-2 (FB)
C17H21ClN2S;320.88
Chlorpromazine N-Desmethyl RBPL-C1706
CARBAMAZEPINE RBPL-C1800 298-46-4 C15H12N2O; 236.27
Carbamazepine Impurity D
(Carbamazepine Related Compound B)
RBPL-C1801 256-96-2 C₁₄H₁₁N; 193.24
Carbamazepine Impurity E RBPL-C1802 494-19-9 C₁₄H₁₃N; 195.26
Carbamazepine N-oxide (Carbamazepine Epoxide) RBPL-C1804 36507-30-9 C₁₅H₁₂N₂O₂; 252.27
Carbamazepine Impurity A
(Carbamazepine Related Compound A)
RBPL-C1805 3564-73-6 C15H14N2O; 238.28
CHLORPHENIRAMINE / CHLORPHENAMINE RBPL-C2300 132-22-9 C16H19ClN2. 274.79
Chlorpheniramine N-Oxide RBPL-C2301 142494-45-9 C16H19ClN2O; 290.79
Chlorpheniramine Impuity B
(Chlorpheniramine Related Compound B)
RBPL-C2302 1202-34-2 C₁₀H₉N₃; 171.2
Chlorpheniramine Impuity C RBPL-C2303
20619-12-9
22630-25-7(FB)
C₁₅H₁₇ClN₂; 260.76
Chlorpheniramine Impuity A RBPL-C2304 1246816-57-8 C16H24ClN3; 293.8
CAFFEINE RBPL-C2500 58-08-2 C8H10N4O2; 194.19
Caffeine Impurity C RBPL-C2501 519-32-4 C₈H₁₀N₄O₂; 194.19
Caffeine Impurity E RBPL-C2502 20041-90-1 C7H12N4O; 168.2
CLOMIPHENE RBPL-C2600 911-45-5 C26H28ClNO; 406.0
Clomiphene N-oxide RBPL-C2601 97642-74-5 C₂₆H₂₈ClNO₂; 421.96
CYPROHEPTADINE RBPL-C2700
Cyproheptadine N-oxide RBPL-C2701 100295-63-4 C₂₁H₂₁NO; 303.41
CHLORAMPHENICOL RBPL-C2900 56-75-7 C11H12Cl2N2O5; 323.13
Chloramphenicol Impurity B RBPL-C2901 555-16-8 C7H5NO3 ; 151.12
Chloramphenicol Impurity RBPL-C2902 2964-48-9 C9H12N2O4; 212.21
CINNARIZINE RBPL-C3700
Cinnarizine N-oxide RBPL-C3702
CYCLOBENZAPRINE RBPL-C4000 303-53-7 C₂₀H₂₁N; 275.39
Cyclobenzaprine N-Oxide RBPL-C4001 6682-26-4 C20H21NO; 291.4
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 5 of 16 
 
CHOLECALCIFEROL RBPL-C4100 67-97-0 C27H44O ; 384.65
CLOBETASOL RBPL-C4200 25122-46-7 C25H32ClFO5; 466.97
Clobetasol Impurity J (Clobetasol Related Compound A) RBPL-C4201 1486466-31-2 C25H30ClFO4;448.95
DICLOFENAC RBPL-D0100 15307-86-5 C14H11Cl2NO2 296.15
Diclofenac Impurity A (Diclofenac Related Compound A)
(Diclofenac Lactum) (Aceclofenac Impurity I)
(Diclofenac Amide)
RBPL-D0101 15362-40-0 C₁₄H₉Cl₂NO; 278.13
Diclofenac isopropyl Impurity RBPL-D0102 66370-79-4 C17H17Cl2NO2; 338.24
Diclofenac methyl ester Impurity (Aceclofenac Impurity B) RBPL-D0103 15307-78-5 C15H13Cl2NO2; 310.18
Diclofenac Impurity F RBPL-D0104 560075-65-2 C14H10Cl3NO; 314.59
Diclofenac Impurity D (Diclofenac Related Compound D) RBPL-D0106 127792-45-4 C14H10BrClNNaO2; 362.58
Diclofenac Free Acid (Aceclofenac Impurity A)
(Diclofenac Impurity K)
RBPL-D0108 15307-86-5 C₁₄H₁₁Cl₂NO₂; 296.15
DOMPERIDONE RBPL-D0200 57808-66-9 C22H24ClN5O2; 425.91
Domperidone Impurity A RBPL-D0201 53786-28-0 C12H14ClN3O; 251.71
Domperidone Impurity B RBPL-D0202 1346598-11-5 C13H14ClN3O2; 279.72
Domperidone Impurity (Droperidol) RBPL-D0203 548-73-2 C22H22FN3O2; 379.43
Domperidone N-oxide (Domperidone Impurity C) RBPL-D0205 118435-03-3 C22H24ClN5O3; 441.9
DESVENLAFAXINE RBPL-D0300 93413-62-8 C16H25NO2; 263.381
Desvenlafaxine-N-oxide RBPL-D0301 NA C16H25NO3; 279.37
DESLORATADINE RBPL-D0500 100643-71-8 C19H19ClN2; 310.82
Desloratadine dehydro impurity RBPL-D0502 117811-20-8 C19H17ClN2; 308.80468
Desloratadine deschloro Impurity RBPL-D0503 38092-95-4 C19H20N2; 276.38
Desloratadine Related Compound F (Desloratadine N-Formyl) RBPL-D0504 117810-61-4 C₂₀H₁₉ClN₂O; 338.83
DIPYRIDAMOLE RBPL-D0600 58-32-2 C24H40N8O4; 504.63
Dipyridamole Impurity A (Dipyridamole Related Compound A) RBPL-D0601 16982-40-4 C₂₅H₄₀N₈O₂; 484.64
Dipyridamole Impurity B (Dipyridamole Related Compound B) RBPL-D0602 16908-47-7 C23H40N8O6; 524.61
Dipyridamole Impurity E (Dipyridamole Related Compound E) RBPL-D0603 2365420-11-5 C24H40N8O4; 504.63
DUTASTERIDE RBPL-D0700 164656-23-9 C27H30F6N2O2; 528.53
Dutasteride Impurity C RBPL-D0701 157307-36-3 C21H31NO3; 345.48
DORZOLAMIDE RBPL-D0800 130693-82-2 C10H16N2O4S3 · HCl; 360.90
Dorzolamide Impurity D (Dorzolamide Related Compound D) RBPL-D0801 164455-27-0 C8H12N2O4S3. HCl; 296.39 36.46
DIPHENHYDRAMINE RBPL-D0900 58-73-1 C17H21NO 255.36
Diphenhydramine Impurity A
(Diphenhydramine Related Compound A)
RBPL-D0901
17471-10-2(FB)
53499-40-4(Hcl)
C16H19NO HCl; 241.34 36.46
DARIFENACIN RBPL-D1000
Free Amine: 133099-04-4
133099-07-7
C₂₈H₃₁BrN₂O₂; 507.46
7-bromoethyl darifenacin RBPL-D1001 NA C10H11BrO; 227.1
Darifenacin N-oxide RBPL-D1002 1391080-40-2 C₂₈H₃₀N₂O₃; 442.55
DONEPEZIL RBPL-D1100 120014-06-4 C24H29NO3, 379.50
Donepezil benzyl bromide (Donepezil Impurity H) RBPL-D1101 844694-85-5 C31H36BrNO3; 550.53
Donepezil dihydro RBPL-D1102 120011-70-3 C₂₄H₃₀ClNO₃; 415.95
Donepezil N-oxide (Donepezil Impurity D) RBPL-D1103 120013-84-5 C₂₄H₂₉NO₄; 395.49
DEXTROMETHORPHAN RBPL-D1600 125-71-3 C18H25NO 271.40
Dextromethorphan N-Oxide RBPL-D1601 1177494-18-6 C18H25NO2; 287.4
DASATINIB RBPL-D1900 302962-49-8 C22H26ClN7O2S; 488.01
Dasatinib N-oxide (Dasatinib Impurity F) RBPL-D1901 910297-52-8 C₂₂H₂₆ClN₇O₃S; 504
DOXEPIN RBPL-D2100 1668-19-5 C19H21NO; 279.383
Doxepin N-Oxide RBPL-D2101 22684-91-9 C₁₉H₂₁NO₂; 295.38
DILTIAZEM RBPL-D2600 42399-41-7 C22H26N2O4S. 414.52
Diltiazem N-oxide (Diltiazem Sulphoxide) RBPL-D2601 142843-04-7 C₂₂H₂₆N₂O₅S; 430.52
Diltiazem Sulphone RBPL-D2602 NA C22H26N2O6S; 446.52
DIGOXIN RBPL-D3000 20830-75-5 C41H64O14; 780.94
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 6 of 16 
 
Digoxin Impurity H RBPL-D3001 17575-22-3 C49H76O20; 985.12
DOXYLAMINE RBPL-D3300
Doxylamine N-oxide (Ethanolamine) RBPL-D33 97143-65-2 Hcl (NA) C₁₇H₂₂N₂O₂; 286.37
DIACEREIN RBPL-D3400
Diacerein Impurity B RBPL-D3401 481-72-1 C15H10O5; 270.24
ETORICOXIB RBPL-E0100 202409-33-4 C18H15ClN2O2S; 358.84
Etoricoxib N-Oxide RBPL-E0101 325855-74-1 C18H15ClN2O3S ; 374.85
ERYTHROMYCIN RBPL-E0200 114-07-8 C37H67NO13; 733.93
Erythromycin Impurity H (Erythromycin N-oxide) RBPL-E0201 992-65-4 C₃₇H₆₇NO₁₄; 749.93
Erythromycin Impurity B (3’N-desmethyl erythromycin A)
(Clarithromycin Impurity R)
RBPL-E0202 992-62-1 C36H65NO13; 719.90
Erythromycin Impurity D (Anhydro Erythromycin) RBPL-E0203 23893-13-2 C₃₇H₆₅NO₁₂; 715.91
Erythromycin Impurity E (Erythromycin A Enol Ether) RBPL-E0204 33396-29-1 C₃₇H₆₅NO₁₂; 715.92
Erythromycin Impurity F (Pseudo Erythromycin A Enol Ether) RBPL-E0205 105822-69-7 C37H65NO12; 715.93
Erythromycin Impurity L
(N-desmethyl – N-formoyl erythromycin A)
RBPL-E0206 127955-44-6 C37H65NO14; 747.91
Erythromycin 9-Oxime Impurity
(Clarithromycin Impurity J) (Azithromycin Impurity S)
(Roxithromycin Impurity C)
RBPL-E0207 13127-18-9 C₃₇H₆₈N₂O₁₃; 748.94
EMTRICITABINE RBPL-E0300 143491-57-0 C8H10FN3O3S; 247.25
Emtricitabine Sulfoxide (Emtricitabine Impurity-G) RBPL-E0301 152128-77-3 C₈H₁₀FN₃O₄S; 263.25
ENALAPRIL RBPL-E0400 75847-73-3 C20H28N2O5 · C4H4O4; 492.52
Enalapril DKP Impurity D RBPL-E0402 115729-52-7 C₂₀H₂₆N₂O₄; 358.43
ERLOTINIB RBPL-E0500 183321-74-6 C22H23N3O4, 393.44
Erlotinib Hcl N-Oxide RBPL-E0501 NA C22H23N3O5 ; 409.44
ENROFLOXACIN RBPL-E0600 93106-60-6 C19H22FN3O3; 359.39
Enrofloxacin N-oxide RBPL-E0603 185460-67-7 C19H22FN3O4; 375.39
Enrofloxacin Methyl Ester RBPL-E0604
ERGOCRYPTINE RBPL-E1500
FAMOTIDINE RBPL-F0100 76824-35-6 C8H15N7O2S3; 337.45
Famotidine Impurity B (Famotidine Related Compound B) RBPL-F0101
109467-08-5 (Dimaleate) ;
89268-62-2
C16H23N11O2S5 ; 561.75
Famotidine Impurity E (Famotidine Related Compound E) RBPL-F0102 129083-44-9 C₁₀H₁₄N₈S₄; 374.53
Famotidine Impurity D (Famotidine Related Compound D) RBPL-F0103 76824-16-3 C8H13N5OS2 ; 259.35
FOSINOPRIL RBPL-F0200 98048-97-6 C30H45NO7P · Na; 585.64
Fosinopril Impurity A (Fosinopril Related Compound A)
(Fosinoprilat)
RBPL-F0201 95399-71-6 C₂₃H₃₄NO₅P; 435.49
FENOFIBRATE RBPL-F0400 49562-28-9 C20H21ClO4; 360.83
Fenofibrate Impurity A (Fenofibrate Related Compound A) RBPL-F0401 42019-78-3 C13H9ClO2; 232.67
Fenofibrate Impurity B (Fenofibrate Related Compound B) RBPL-F0402 42017-89-0 C17H15ClO4; 318.75
Fenofibrate Impurity G (Fenofibrate Related Compound C) RBPL-F0403 217636-48-1 C24H27ClO6; 446.92
Fenofibrate Impurity C RBPL-F0404 217636-47-0 C17H15ClO3; 302.75
Fenofibrate Impurity F RBPL-F0405 154356-96-4 C16H15ClO2; 274.74
FINASTERIDE RBPL-F0500 98319-26-7 C23H36N2O2; 372.54
Finasteride Impurity A RBPL-F0501 98319-24-5 C₂₃H₃₈N₂O₂ ; 374.56
Finasteride Impurity B RBPL-F0502 103335-41-7 C₂₀H₂₉NO₃; 331.45
FLUTICASONE RBPL-F0600 80474-14-2 C25H31F3O5S; 500.57
Fluticasone Related Compound A RBPL-F0601 948566-12-9 C₂₄H₃₀F₂O₆S; 484.55
Fluticasone Related Compound C RBPL-F0602 80474-24-4 C₂₄H₂₉F₃O₅S; 486.54
Fluticasone Related Compound D RBPL-F0603 73205-13-7 C₂₅H₃₂F₂O₅S; 482.58
FEXOFENADINE RBPL-F0700 83799-24-0 C32H39NO4; 501.667
Fexofenadine Impurity A
(Fexofenadine Related Compound A)
RBPL-F0701 76811-98-8 C₃₂H₃₇NO₄; 499.64
Fexofenadine Impurity C RBPL-F0702 185066-37-9 C31H39NO2; 457.64
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 7 of 16 
 
Fexofenadine N-Oxide RBPL-F0703 1422515-52-3 C32H39NO5; 517.67
FUROSEMIDE RBPL-F1100 54-31-9 C12H11ClN2O5S; 330.74
Furosemide Impurity C (Furosemide Related Compound B) RBPL-F1102 3086-91-7 C7H7ClN2O4S; 250.66
FOLIC ACID RBPL-F1300 59-30-3 C19H19N7O6; 441.40
Folic acid Impurity A RBPL-F1302 4271-30-1 C12H14N2O5; 266.25
Folic acid Impurity D RBPL-F1303 119-24-4 C₁₄H₁₂N₆O₃; 312.28
FLAVOXATE RBPL-F1600 15301-69-6 C24H25NO4, 391.46.
Flavoxate N-Oxide (HCl) RBPL-F1602 407.52
FENSPIRIDE RBPL-F1700 5053-06-5 C15H16D5ClN2O2, 301.82.
Fenspiride N-Oxide RBPL-F1701 210690-26-9 C15H20N2O3, 276.33
FELODIPINE RBPL-F1900 72509-76-3 C18H19Cl2NO4; 383.069
Felodipine Related Compound A RBPL-F1901 96382-71-7 C18H17Cl2NO4 382.24
FENPIVERINIUM RBPL-F2000
Fenpiverinium Bromide Impurity A RBPL-F2001 77-01-0 C21H26N2O; 322.45
FLUOXETINE RBPL-F2100
Fluoxetine Dimethyl Amine RBPL-F2101 885101-12-2 C18H21ClF3NO;359.81
GALANTAMINE RBPL-G0100 357-70-0 C17H21NO3, 287.35
Galantamine Impurity B (Epi Galantamine) RBPL-G0101 1668-85-5 C17H21NO3; 287.35
Galantamine Impurity D (Anhydro Galantamine) RBPL-G0102 664995-65-7 C17H19NO2; 269.34
O-desmethyl Galantamine RBPL-G0103 60755-80-8 C₁₆H₁₉NO₃; 273.33
Galantamine N-Oxide RBPL-G0104 134332-50-6 C₁₇H₂₁NO₄; 303.35
Galantamine Impurity E RBPL-G0105 41303-74-6 C16H1z NO3 ; 273.33
Galantamine Impurity C RBPL-G0106 21133-52-8 C17 H23 NO3 ; 289.38
GABAPENTIN RBPL-G0200 60142-96-3 C9H17NO2 171.24
Gabapentin Impurity A (Gabapentin Related Compound A) RBPL-G0201 64744-50-9 C₉H₁₅NO; 153.22
Gabapentin Impurity B (Gabapentin Related Compound B) RBPL-G0202 133481-09-1 C₉H₁₃NO₂; 167.21
Gabapentin Impurity D (Gabapentin Related Compound D) RBPL-G0203 1076198-17-8 C₁₈H₂₉NO₃; 307.43
Gabapentin Impurity E (Gabapentin Related Compound E) RBPL-G0204 67950-95-2 C9H14O4; 186.21
GLIMEPIRIDE RBPL-G0300 93479-97-1 C24H34N4O5S; 490.62
Glimepiride Impurity B (Glimepiride Related Compound B) RBPL-G0301 119018-29-0 C₁₆H₂₁N₃O₄S; 351.42
Glimepiride Impurity A (Glimepiride Related Compound A) RBPL-G0302 684286-46-2 C₂₄H₃₄N₄O₅S; 490.62
Glimepiride Impurity C (Glimepiride Related Compound C) RBPL-G0303 119018-30-3 C₁₈H₂₃N₃O₆S; 409.46
Glimepiride Impurity D (Glimepiride Related Compound D) RBPL-G0304 791104-62-6 C₂₄H₃₄N₄O₅S; 490.62
GLICLAZIDE RBPL-G0400 21187-98-4 C15H21N3O3S; 323.41
Gliclazide Impurity B RBPL-G0401 54786-86-6 C7H12N2O; 140.18
Gliclazide Impurity F RBPL-G0402 1076198-18-9 C15H21N3O3S; 323.41
GUAIFENESIN RBPL-G0500 93-14-1 C10H14O4; 198.22
Guaifenesin Impurity B (Guaifenesin Related Compound B) RBPL-G0501 14007-09-1 C₁₀H₁₄O₄; 198.22
GEFITINIB RBPL-G0600 184475-35-2 C22H24ClFN4O3; 446.91
Gefitinib Morpholine N-oxide RBPL-G0601 847949-51-3 C22H24ClFN4O4 ; 462.91
GLIBENCLAMIDE RBPL-G0900 10238-21-8 C23H28ClN3O5S; 494.004
Glibenclamide Impurity A RBPL-G0901 16673-34-0 C16H17ClN2O4S; 368.84
Glibenclamide Impurity B RBPL-G0902 21165-77-5 C18H19ClN2O6S; 426.87
HALOPERIDOL RBPL-H0300 52-86-8 C21H23ClFNO2 375.86
Haloperidol N-Oxide (Haloperidol Impurity–H) RBPL-H0301 148406-51-3 C₂₁H₂₃ClFNO₃; 391.86
HYDROCORTISONE ACETATE RBPL-H0500 50-03-3 C23H32O6; 404.50
HYDROXYCHLOROQUINE RBPL-H0600 118-42-3 C18H26ClN3O; 335.872
Hydroxychloroquine N-oxide RBPL-H0601
IMATINIB RBPL-I0100 152459-95-5 C29H31N7O; 493.60
Imatinib Impurity E (Imatinib Dimer) RBPL-I0101 1365802-18-1 C₅₂H₄₈N₁₂O₂; 873.02
Imatinib (Pyridine) N-oxide RBPL-I0102 571186-92-0 C29H31N7O2; 509.60
Imatinib piperazine N-Oxide RBPL-I0103 571186-91-9 C29H31N7O2; 509.62
Imatinib (Piperidine)-N,N-dioxide RBPL-I0104 571186-93-1 C₂₉H₃₁N₇O₃ ; 525.60
IBUPROFEN RBPL-I0200 15687-27-1 C13H17O2; 205.27
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 8 of 16 
 
Ibuprofen Impurity L RBPL-I0201 53949-53-4 C13H18O3; 222.28
Ibuprofen Impurity E (Ibuprofen Related Compound C) RBPL-I0202 38861-78-8 C12H16O; 176.25
Ibuprofen Impurity A RBPL-I0203 66622-47-7 C₁₃H₁₈O₂; 206.28
Ibuprofen Impurity N RBPL-I0204 3585-52-2 C₁₁H₁₄O₂; 178.23
Ibuprofen Impurity B RBPL-I0205 3585-49-7 C13H18O2; 206.28
Ibuprofen Impurity J (Ibuprofen Related Compound J) RBPL-I0206 65813-55-0 C₁₃H₁₆O₃; 220.26
Ibuprofen impurity F RBPL-I0207 65322-85-2 C13H18O2; 206.28
ITRACONAZOLE RBPL-I0300 84625-61-6 C35H38Cl2N8O4; 705.63
Itraconazole Impurity C RBPL-I0301 74855-91-7 C34H36Cl2N8O4; 691.61
Itraconazole N,N-dioxide RBPL-I0302 NA C₃₅H₃₈Cl₂N₈O6; 737.63
Itraconazole N-oxide RBPL-I0302 NA C35H38Cl2N8O; 721.65
IRBESARTAN RBPL-I0500
Irbesartan Related Compound A RBPL-I0501 748812-53-5 C25H30N6O2; 446.54
INDORAMIN RBPL-I1000
Indoramin Impurity C RBPL-I1001 33953-37-6 C₁₂H₁₆N₂O;204.27
Indoramin Hcl Impurity A RBPL-I1002 3389-21-7
INDOMETACIN RBPL-I1100 53-86-1 C19H16ClNO4 357.79
KETORALAC RBPL-K0100 74103-06-3 C15H13NO3, 255.27
Ketoralac Impurity D RBPL-K0101 1391053-45-4 C16H14NNaO4 ;307.0821; 285
Ketorolac Impurity B (Ketorolac Related Compound C) RBPL-K0102 113502-52-6 C₁₄H₁₁NO₂; 225.24
Ketorolac Impurity E (Ketorolac Related Compound A) RBPL-K0103 167105-80-8 C19H22N2O5; 358.39
Ketorolac Impurity A (Ketorolac Related Compound B) RBPL-K0104 154476-25-2 C₁₄H₁₃NO₂; 227.26
Ketorolac Impurity I (Ketorolac Related Compound D) RBPL-K0105 113502-55-9 C₁₄H₁₃NO; 211.26
KETOCONAZOLE RBPL-K0200 65277-42-1 C26H28Cl2N4O4; 531.43
Ketoconazole-N-Oxide RBPL- K0201 254912-65-7 C26H28Cl2N4O5; 547.43
Ketoconazole Impurity D RBPL- K0202 67914-61-8 C24H26Cl2N4O3; 489.4
KETOPROFEN RBPL-K0300
Ketoprofen Methyl Ester RBPL-K0301
LEFLUNOMIDE RBPL-L0200 75706-12-6 C12H9F3N2O2; 270.21
Leflunomide Impurity E RBPL-L0201 208401-20-1 C₁₂H₉F₃N₂O₂; 270.21
LAMOTRIGINE RBPL-L0300 84057-84-1 C9H7Cl2N5 256.09
Lamotrigine Impurity F (Lamotrigine Related Compound D) RBPL-L0301 252186-79-1 C16H9Cl4N5O; 429.09
Lamotrigine Impurity G RBPL-L0302 38943-76-9 C9H5Cl2N3O2; 258.06
Lamotrigine N-Oxide RBPL-L0303 136565-76-9 C₉H₇Cl₂N₅O; 272.09
LANSOPRAZOLE RBPL-L0400 103577-45-3 C16H14F3N3O2S; 369.36
Lansoprazole sulphone (Lansoprazole Impurity-B)
(Lansoprazole Related Compound A)
RBPL-L0401 131926-99-3 C₁₆H₁₄F₃N₃O₄S; 385.36
Lansoprazole sulphone (Lansoprazole N-oxide) RBPL-L0402 953787-54-7 C16H14F3N3O4S; 401.36
Lansoprazole Impurity C (Lansoprazole Sulphide)
(Lansoprazole Related Compound B)
RBPL-L0403 103577-40-8 C16H14F3N3OS; 353.36
Lansoprazole chloro RBPL-L0404 127337-60-4 C9H10Cl2F3NO; 276.08
Lansoprazole Impurity E
(Rabeprazole Related Compound C) (Rabeprazole Impurity F)
RBPL-L0405 583-39-1 C8H6F2N2OS; 216.21
S-Lansoprazole RBPL-L0406 138530-95-7 C16H14F3N3O2S; 369.36
LEVOFLOXACIN RBPL-L0500 100986-85-4 C18H20FN3O4; 361.37
Levofloxacin Hemihydrate RBPL-L0500 138199-71-0 C18H20FN3O4.1/2.H2O; 370.38
Levofloxacin Impurity F (Levofloxacin Related Compound B) RBPL-L0501 100986-89-8 C₁₃H₉F₂NO₄; 281.21
Levofloxacin-N-oxide (Impurity C) RBPL-L0502 117678-38-3 C18H20FN3O5; 377.36
Levofloxacin Impurity B (Levofloxacin Related Compound A)
(Levofloxacin N-desmethyl)
RBPL-L0503 117707-40-1 C17H18FN3O4; 347.34
Levofloxacin Impurity A (Levofloxacin D-Isomer) RBPL-L0504 100986-86-5 C18H20FN3O4 ; 361.37
Levofloxacin Impurity G (Levofloxacin Related Compound E) RBPL-L0505 1346603-62-0 C16H18FN3O4; 371.79
LOPERAMIDE RBPL-L0600 53179-11-6 C29H33ClN2O2, 477.04
Loperamide Impurity B RBPL-L0601 NA C47H53ClN3O3; 743.4
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 9 of 16 
 
Loperamide Impurity F (Loperamide Trans-N-Oxide)
(Loperamide Related Compound F)
RBPL-L0602 106900-12-3 C29H33ClN2O3; 493.05
Loperamide Impurity G (Cis-N-Oxide) RBPL-L0603 109572-89-6 C29H33ClN2O3; 493.04
Loperamide Impurity A RBPL-L0604 1391052-94-0 C35H37ClN2O2; 553.143
Loperamide Impurity C RBPL-L0605 39512-49-7 C₁₁H₁₄ClNO; 211.69
Loperamide Impurity H (Anhydro Loperamide) RBPL-L0606 61299-42-1 C₂₉H₃₁ClN₂O; 459.02
LORATADINE RBPL-L0700 79794-75-5 C22H23N2O2Cl; 382.88
Loratadine Impurity D (Loratadine Related Compound A) RBPL-L0702 100643-71-8 C19H19ClN2; 310.82
Loratadine Impurity B (Loratadine Related Compound C) RBPL-L0703 31251-41-9 C₁₄H₁₀ClNO; 243.69
LAMIVUDINE RBPL-L0900 134678-17-4 C8H11N3O3S; 229.26
Lamivudine R-Sulphoxide RBPL-L0903 160552-54-5 C₈H₁₁N₃O₄S; 245.26
LEVOCETRIZINE RBPL-L1000
Levocetrizine Amide RBPL-L1001 909779-33-5 C21H26ClN3O2; 387.90
Levocetrizine CBHP (Chlorobenzyldryl Piperazine) RBPL-L1002 300543-56-0 C₁₇H₁₉ClN₂; 286.8
LEVETIRACETAM RBPL-L1100 102767-28-2 C8H14N2O2; 170.21
Levetiracetam Impurity G
(Levetiracetam Related Compound B)
RBPL-L1101 7682-20-4 C₄H₁₁ClN₂O; 138.6
LIDOCAINE RBPL-L1500 137-58-6 C14H22N2O; 234.34
Lidocaine N-Oxide RBPL-L1503 2903-45-9 C14H22N2O2; 250.34
LINEZOLID RBPL-L1900 165800-03-3 C16H20FN3O4; 337.35
Linezolid N-oxide RBPL-L1901 189038-36-6 C16H20FN3O5; 353.35
Linezolid Related Compound A RBPL-L1902 168828-84-0 C14H16FN5O3; 321.31
LUMEFANTRINE RBPL-L2000 82186-77-4 C30H32Cl3NO; 528.94
Lumefantrine N-oxide RBPL-L2001 NA C30H32NO2Cl3; 543.15
METOPROLOL RBPL-M0200 37350-58-6 C15H25NO; 267.36
Metoprolol Epoxide RBPL-M0201 56718-70-8 C₁₂H₁₆O₃; 208.25
Metoprolol Impurity H (Betaxolol Impurity B) RBPL-M0202 62572-94-5 C₁₄H₂₃NO₃; 253.34
Metoprolol Impurity B RBPL-M0203 56718-71-9 C₉H₁₂O₂ ; 152.19
Metoprolol Impurity G RBPL-M0204 501-94-0 C₈H₁₀O₂ ; 138.16
Metoprolol Impurity M RBPL-M0205 73313-36-7 C₉H₂₄Cl₂N₂O ; 247.21
Metoprolol Impurity N RBPL-M0206 6452-57-9 (FB) C₆H₁₅NO₂; 133.19
Metoprolol Impurity O (Metoprolol Related Compound D) RBPL-M0207
154784-36-8
1486464-40-7 (Hcl)
C₂₇H₄₁NO₆; 475.6
Metoprolol Impurity C (Metoprolol Related Compound C) RBPL-M0208 29122-74-5
C₁₃H₁₉NO₃; 237.29;
(C17H23NO7 ; 353.15) maleate
Metoprolol Impurity D RBPL-M0209 62572-90-1 C12H18O4; 226.268
Metoprolol Impurity A (Metoprolol Related Compound A) RBPL-M0210 109632-08-8 C₁₄H₂₃NO₃, 253.34
Succinic acid RBPL-M0211 110-15-6 C4H6O4; 118.09
METOCLOPRAMIDE RBPL-M0300 364-62-5 C14H22ClN3O2; 299.8
Metoclopramide Impurity H RBPL-M0301 50-86-2 C9H9NO4; 195.17
Metoclopramide N-oxide (Metoclopramide Impurtiy G) RBPL-M0303 171367-22-9 C₁₄H₂₂ClN₃O₃; 315.8
Metoclopramide Impurity A
(Metoclopramide Related Compound A)
RBPL-M0304 5608-13-9 C16H24ClN3O3; 341.83
Metoclopramide Impurity E RBPL-M0305 100-36-7 C6H16N2; 116.21
MEFENAMIC ACID RBPL-M0400 61-68-7 C15H15NO2; 241.29
Mefenamic Acid Impurity C RBPL-M0401 118-91-2 C₇H₅ClO₂;156.57
Mefenamic Acid Impurity D RBPL-M0402 65-85-0 C₇H₆O₂; 122.12
Mefenamic Acid Impurity A RBPL-M0403 87-59-2 C8H11N; 121.18
MYCOPHENOLATE RBPL-M0500 24280-93-1 C17H20O6; 320.34
Mycophenolate Impurity F (Mycophenolic Acid) RBPL-M0501 24280-93-1 C₁₇H₂₀O₆; 320.34
Mycophenolate Mofetil N-Oxide (Mycophenolate Impurity G) RBPL-M0502 224052-51-1 C₂₃H₃₁NO₈; 449.49
MONTELUKAST RBPL-M0600 158966-92-8 C35H36ClNO3S. 586.18
Montelukast Dicyclo Hexyl Amine RBPL-M0600 577953-88-9 C47H59ClN2O3S; 767.5
Montelukast Sulfoxide (Montelukast Impurity C)
(Montelukast Related Compound A)
RBPL-M0601 909849-96-3 C₃₅H₃₆ClNO₄S 602.18
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 10 of 16 
 
Montelukast Sulphone RBPL-M0602 1266620-74-9 C₃₅H₃₆ClNO₅S618.18
Montelukast Ketone RBPL-M0603 1258428-71-5 C29H26ClNO2 ; 455.98
Montelukast methylstyrene (Montelukast Impurity-B)
(Montelukast Related Compound F)
RBPL-M0604 918972-54-0 C35H34ClNO2S ; 568.17
MOXIFLOXACIN RBPL-M0700 354812-41-2 C21H24FN3O4; 401.43
Moxifloxacin Impurity A (Moxifloxacin Related Compound A) RBPL-M0701 151213-15-9 C20H21F2N3O3; 389.40
MODAFINIL RBPL-M0800 68693-11-8 C15H15NO2S; 273.35
Modafinil Sulphone RBPL-M0801
Modafinil Impurity B (Modafinil Related Compound B) RBPL-M0802 118779-53-6 C15H15NO3S; 28; .35
MELOXICAM RBPL-M0900 71125-38-7 C14H13N3O4S2; 351.40
Meloxicam Impurity B (Meloxicam Related Compound B) RBPL-M0901 7305-71-7 C4H6N2S ; 114.17
MEMANTINE RBPL-M1000 19982-08-2 C12H21N; 79.30
Memantine N-oxide RBPL-M1006 1262583-10-7 C₁₂H₁₉NO; 193.29
METFORMIN RBPL-M1200 657-24-9 C4H11N5; 129.16
Metformin Impurity A (Metformin Related Compound A) RBPL-M1201 461-58-5 C₂H₄N₄; 84.08
Metformin Impurity C (Metformin Related Compound C) RBPL-M1202 1985-46-2 C₅H₁₀N₆; 154.17
Metformin Impurity D RBPL-M1203 108-78-1 C₃H₆N₆; 126.12
MIRTAZAPINE RBPL-M1300 61337-67-5 C17H19N3; 265.35
Mirtazapine N-oxide RBPL-M1301 155172-12-6 C17H19N3O; 281.35
MINOXIDIL RBPL-M1800 38304-91-5 C9H15N5O; 209.253
Minoxidil Impurity E (Deoxy Minoxidil) RBPL-M1802 24867-26-3 C9H15N5;193.25
METHYL PARABEN RBPL-M2300 99-76-3 HOC6H4CO2CH3; 152.15
MBTH Hydrochloride RBPL-M2500 4338-98-1 C₈H₉N₃S • HCl; 215.7
3-methyl-2-benzothiazolinonehydrazone Hydrochloride
(MBTH)
RBPL-M2501 4338-98-1 C₈H₉N₃S • HCl; 215.7
METHYLCOBALAMINE RBPL-M2600 13422-55-4 C63H91CoN13O14P, 1344.38
NIMSULIDE RBPL-N0100 51803-78-2 C13H12N2O5S; 308.31
Nimsulide Impurity D RBPL-N0101 5422-92-4 C12H10N2O3; 230.22
NORADRENALIN RBPL-N0200 51-41-2 C8H11NO3; 169.180
Noradrenalin Impurity E RBPL-N0201 99-40-1 C8H7ClO3; 186.59
Noradrenalin Impurity F RBPL-N0202 20455-68-9 C14H16ClN; 233.74
NAPROXEN RBPL-N0300 22204-53-1 C14H14O3; 230.26
Naproxen Impurity B RBPL-N0301 89617-86-7 C₁₄H₁₃ClO₃; 264.7
Naproxen Impurity D RBPL-N0302 116883-62-6 C₁₄H₁₃IO₃; 356.16
Naproxen Impurity K RBPL-N0303 77301-42-9 C₁₃H₁₄O₂; 202.25
Naproxen Impurity L (Naproxen Related Compound L) RBPL-N0304 3900-45-6 C₁₃H₁₂O₂; 200.23
Naproxen Impurity N RBPL-N0305 5111-65-9 C₁₁H₉BrO; 237.09
Racemic Naproxen RBPL-N0306 23981-80-8 C₁₄H₁₄O₃; 230.26
Naproxen Impurity O (Naproxen Related Compound A) RBPL-N0307 2471-70-7 C₁₂H₁₀O₃; 202.21
Naproxen Methyl Ester RBPL-N0308
Naproxen Ethyl Ester RBPL-N0309
Naproxen Isopropyl Ester RBPL-N0310
NIZATIDINE RBPL-N0400 76963-41-2 C12H21N5O2S2 331.45
Nizatidine Impurity H RBPL-N0401 27366-72-9 C₄H₁₁ClN₂S; 154.66
NEBIVOLOL RBPL-N0500 99200-09-6 C22H25F2NO4; 405.44
Nebivolol Impurity A RBPL-N0501 118457-16-2 C22H25F2NO4; 405.45
Nebivolol Impurity B (Nebivolo Related Compound B) RBPL-N0502 119365-25-2 C22H25F2NO4; 405.45
NIACINAMIDE RBPL-N0700 98-92-0 C6H6N2O; 122.12
Niacinamide N-oxide RBPL-N0701 1986-81-8 C6H6N2O2;138.13
Nicotinamide Impurity D (Nicotine impurity C)
(Isonicotinamide)
RBPL-N0702 1453-82-3 C₆H₆N₂O; 122.12
NIFEDIPINE RBPL-N0800 21829-25-4 C₁₇H₁₈N₂O₆; 346.33
Nifedipine Impurity B RBPL-N0801 50428-14-3 C17H16N2O5; 328.32
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 11 of 16 
 
NILOTINIB RBPL-N1100 641571-10-0 C28H22F3N7O; 529.5245
Nilotinib Impurity C RBPL-N1101 641571-15-5 C28H22F3N7O; 529.53
NALIDIXIC ACID RBPL-N1200
Nalidixic Acid Impurity C RBPL-N1201 87-13-8 C10H16O5; 216.23
NIMODIPINE RBPL-N1300
Nimodipine Impurity A RBPL-N1301
OLANZAPINE RBPL-O0100 132539-06-1 C17H20N4S, 312.43
Olanzapine Impurity D (Olanzapine Related Compound C)
(Olanzapine N-oxide)
RBPL-O0101 174794-02-6 C17H20N4OS; 328.43
Olanzapine Impurity A (Olanzapine Related Compound A) RBPL-O0102 138564-59-7 C12H9N3O2S; 259.28
Olanzapine Impurity B (Olanzapine Related Compound B) RBPL-O0103 221176-49-4 C12H10N2OS; 230.29
N-Desmethyl Olanzapine RBPL-O0105 161696-76-0 C₁₆H₁₈N₄S; 298.41
OMEPRAZOLE RBPL-O0200 73590-58-6 (FB) C17H19N3O3S; 345.42
Omeprazole Impurity A (Omeprazole Related Compound B) RBPL-O0201 37052-78-1 C8H8N2OS; 180.23
Omeprazole Impurity C (Omeprazole Sulphide) RBPL-O0202 73590-85-9 C17H19N3O2S; 329.42
Omeprazole Impurity F&G RBPL-O0203
125656-82-8 +
125656-83-9
C16H13N3O2S; 311.4
Omeprazole Impurity I (Omeprazole Sulfone N-Oxide) RBPL-O0205 158812-85-2 C17H19N3O5S; 377.41
4-Hydroxy omeprazole sulphide RBPL-O0206 103876-98-8 C16H17N3O2S; 315.39
Omeprazole Related Compound A (Omeprazole Impurity D)
(Omeprazole Sulphone)
RBPL-O0207 88546-55-8 C₁₇H₁₉N₃O₄S ; 361.42
Omeprazole Impurity E (Omeprazole N-oxide)
(Omeprazole Related Compound E)
RBPL-O0208 176219-04-8 C₁₇H₁₉N₃O₄S ; 361.42
Omeprazole Impurity B (Esomeprazole Impurity B) RBPL-O0209 110374-16-8 C16H17N3O2S ; 315.39
Omeprazole Impurity H RBPL-O0210 863029-89-4 C₁₆H₁₆ClN₃O₂S; 349.84
OFLOXACIN RBPL-O0300 82419-36-1 C18H20FN3O4; 361.37
Ofloxacin Impurity E (Ofloxacin Related Compound A) RBPL-O0301 82419-52-1 C₁₇H₁₈FN₃O₄ ; 347.34
Ofloxacin N-oxide RBPL-O0302 104721-52-0 C₂₀H₂₄FN₃O₇; 437.42
ONDANSETRON RBPL-O0400 99614-02-5 C18H19N3O; 293.36
Ondansetron Impurity D (Ondansetron Related Compound D) RBPL-O0401 99614-64-9 C₁₄H₁₃NO; 211.26
Ondansetron Impurity B RBPL-O0407 1076198-52-1 C₃₇H₃₈N₆O₂; 598.74
OXYBUTYNIN RBPL-O0500 5633-20-5 C22H31NO3, 357.49
Oxybutynin Impurity D (Oxybutynin Related Compound A) RBPL-O0501 4335-77-7 C14H18O3; 234.29
Phenylcyclohexylglycolic Acid Propargyl Ester RBPL-O0502 81039-74-9 C17H20O3; 272.34
OLMESARTAN RBPL-O0700 144689-63-4 C29H30N6O6; 558.59
Olmesartan Impurity A RBPL-O0701 144689-24-7 C₂₄H₂₆N₆O₃; 446.5
Olmesartan Impurity B (Olmesartan Related Compound A) RBPL-O0702 849206-43-5 C₂₄H₂₄N₆O₂; 428.49
OSIMERTINIB RBPL-O0800 1421373-65-0 C₂₈H₃₃N₇O₂; 499.61
Osimertinib N-Oxide RBPL-O0801 1975982-94-5 C₂₈H₃₃N₇O₃ ; 515.61
PIOGLITAZONE RBPL-P0100 112529-15-4 C19H20N2O3S·HCl; 392.90
Hydroxy Pioglitazone RBPL-P0102 146062-44-4 C₁₉H₂₀N₂O₄S; 372.44
PARACETAMOL / ACETAMINOPHEN RBPL-P0200 103-90-2 CH3CONHC6H4OH; 151.16
Paracetamol Impurity J
(Acetaminophen Related Compound J)
RBPL-P0201 539-03-7 C8H8ClNO; 169.61
Paracetamol Impurity F
(Paracetamol Related Compound F) (4-Nitrophenol)
RBPL-P0202 100-02-7 C6H5NO3; 139.11
Paracetamol Impurity K (Related Compound K)
(4-Aminophenol)
RBPL-P0203
51-78-5 (HCl)
123-30-8 (FB)
C6H7NO.HCl; 109.13; 145.59
Paracetamol Impurity A
(Acetaminophen Related Compound C)
RBPL-P0204 614-80-2 C₈H₉NO₂; 151.16
Paracetamol Impurity B
(Acetaminophen Related Compound B)
RBPL-P0205 1693-37-4 C9H11NO2;165.19
PROPAFENONE RBPL-P0300 54063-53-5 C21H27NO3; 341.44
Propafenone Impurity A RBPL-P0301 3516-95-8 C15H14O2; 226.27
Propafenone Impurity C RBPL-P0302 22525-95-7 C18H18O3; 282.33
Propafenone Impurity E RBPL-P0304 165279-79-8 C18H19ClO3; 318.79
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 12 of 16 
 
Propafenone Impurity F RBPL-P0305 1329643-40-4 C33H32O5; 508.6
Propafenone Impurity H RBPL-P0306 27439-12-9 C15H12O2; 224.2
PROMETHAZINE RBPL-P0400 60-87-7 C17H20N2S; 284.42
Promethazine Impurity D (Promethazine Sulphoxide) RBPL-P0401 7640-51-9 C17H20N2OS; 300.42
Promethazine Impurity A RBPL-P0402 92-84-2 C12H9NS; 199.27
Promethazine Impurity B (Promethazine Related Compound
B) (Iso Promethazine)
RBPL-P0403 5568-90-1 C₁₇H₂₁ClN₂S; 320.88
Promethazine Impurity C (N-Demethyl Promethazine) RBPL-P0404 60113-77-1 C₁₆H₁₉ClN₂S; 306.85
PACLITAXEL RBPL-P0500 33069-62-4 C47H51NO14; 853.91
Paclitaxel Related Compound B (Paclitaxel Impurituy H) RBPL-P0501 78454-17-8 C45H49NO13; 811.87
PROPRANOLOL RBPL-P0600 525-66-6 C16H21NO2; 259.34
Propranolol Impurity A (Propranolol Related Compound A) RBPL-P0601 36112-95-5 C₁₃H₁₄O₃; 218.25
Propranolol Impurity C RBPL-P0602 17216-10-3 C₂₃H₂₀O₃; 344.4
PALONOSETRON RBPL-P0700
135729-62-3
Free cmpd: 135729-61-2
C₁₉H₂₄N₂O • (HCl); 296.41
Dehydropalonosetron RBPL-P0701 NA C19H23ClN2O; 330.85
PANTOPRAZOLE RBPL-P0800 102625-70-7 C16H15F2N3O4S, 383.37
Pantoprazole Impurity A (Pantoprazole Related Compound A)
(Pantoprazole Sulphone)
RBPL-P0801 127780-16-9 C₁₆H₁₅F₂N₃O₅S399.37
Pantoprazole Impurity B (Pantoprazole Related Compound B)
(Pantoprazole Sulfide)
RBPL-P0802 102625-64-9 C₁₆H₁₅F₂N₃O₃S367.37
Pantoprazole Impurity C (Pantoprazole Related Compound C) RBPL-P0803 97963-62-7 C₈H₆F₂N₂OS; 216.21
Pantoprazole Sulfone (Pantoprazole N-oxide) RBPL-P0804 953787-55-8 C₁₆H₁₅F₂N₃O₆S415.37
PAROXETINE RBPL-P0900 61869-08-7 C19H20FNO3; 329.37
Paroxetine Impurity I RBPL-P0901 220548-73-2 C₁₂H₁₇ClFNO; 245.72
PYRIDOXINE RBPL-P1100 65-23-6 C8H11NO3; 169.18
Pyridoxine Impurity B Hcl RBPL-P1101 148-51-6 Hcl C₈H₁₂ClNO₂; 189.64
Pyridoxine Impurity A Hcl RBPL-P1102 1006-21-9 C8H9NO2 ; HCl; 151.17 ; 36.46
PARBENDAZOLE RBPL-P1200 14255-87-9 C13H17N3O2; 247.29
PREGABALIN RBPL-P1300 148553-50-8 C8H17NO2; 159.23
Pregabalin Impurity PG-3 (Pregabalin Impurity 4) RBPL-P1301 75143-89-4 C₉H₁₆O₄; 188.22
Pregabalin Impurity PG-2 (Pregabalin Impurity 9) RBPL-P1302 916982-10-0 C₉H₁₅NO₂; 169.22
Pregabalin Related Compound C (Pregabalin Lactam) RBPL-P1303 61312-87-6 C₈H₁₅NO;141.21
Pregabalin Inhouse Impurity (Pregabalin Impurity 5) RBPL-P1304 181289-15-6 C₉H₁₇NO₃; 187.24
Pregabalin Impurity A (Pregabalin Related Compound C)
((S)-Pregabalin Lactam)
RBPL-P1305 181289-23-6 C₈H₁₅NO; 141.21
Pregabalin Impurity B (Pregabalin Related Compound A)
((R)-Pregabalin) (Pregabalin enantiomer)
RBPL-P1307 148553-51-9 C₈H₁₇NO₂; 159.23
Pregabalin Impurity C RBPL-P1308 90-64-2 C₈H₈O₃; 152.15
Pregabalin Impurity D RBPL-P1309 4118-51-8 C₁₁H₁₄O₃; 194.23
PHENYTOIN RBPL-P1400 57-41-0 C15H12N2O2; 252.27
Phenytoin Impurity C (Phenytoin Related Compound A) RBPL-P1403 3060-50-2 C₁₄H₁₃NO₂; 227.26
PALIPERIDONE RBPL-P1500 144598-75-4 C23H27FN4O3; 426.48
Palliperidone N-oxide RBPL-P1501 761460-08-6 C₂₃H₂₇FN₄O₄; 442.48
PRAZIQUANTEL RBPL-P2100 55268-74-1 C19H24N2O2; 312.41
Praziquantel Impurity A (Praziquantel Related Compound A) RBPL-P2101 54761-87-4 C19H18N2O2; 306.36
PHENYLALANINE RBPL-P2200 150-30-1 C9H11NO2; 165.19
Phenylalanine Impurity C RBPL-P2201
60-18-4
Hydrochloride: 16870-43-2
C₉H₁₁NO₃; 181.19
QUETIAPINE RBPL-Q0100 111974-69-7 C₂₁H₂₅N₃O₂S; 383.51
Quetiapine Impurity S (Quetiapine S-oxide) RBPL-Q0101 329216-63-9 C21H25N3O3S; 399.51
Quetiapine Impurity F (II) RBPL-Q0102 848814-27-7 (FB) C21H27N3O3S; 401.52
Quetiapine Impurity D (Quetiapine Dimer) RBPL-Q0103 945668-94-0 C30H24N4S2; 504.67
Quetiapine Impurity J RBPL-Q0104 1356906-17-6 C25H33N3O4S;471.61
Quetiapine Impurity P (Quetiapine N-Ethyl) RBPL-Q0105 1011758-03-4 C19H21N3S; 323.46
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 13 of 16 
 
Quetiapine Impurity Q RBPL-Q0105 011758-03-4 C25H34N3O4S;472.62
Quetiapine Impurity H (Quetiapine N-Oxide) RBPL-Q0106 1076199-40-0 C₂₁H₂₅N₃O₃S; 399.51
Quetiapine Impurity I (Desethoxy Quetiapine) RBPL-Q0107
329216-67-3 (base);
329218-14-6 (2HCl)
C19H21N3OS; 339.45
Quetiapine Impurity N (Quetiapine S,N-Oxide) RBPL-Q0108 1800291-86-4 C₂₉H₄₁N₅O₃S ; 539.73
Quetiapine Impurity R RBPL-Q0109 2459-05-4 C₆H₈O₄; 144.13
Quetiapine Impurity G (Quetiapine Related Compound G) RBPL-Q0110 3159-07-7 C₁₃H₉NOS; 227.28
QUINAPRIL RBPL-Q0200 85441-61-8 C25H30N2O5; 438.47
Quinapril Impurity C (Quinapril Related Compound B) RBPL-Q0201 82768-85-2 C₂₃H₂₆N₂O₅; 410.46
QUINIDINE SULPHATE RBPL-Q0300 6591-63-5
C40H48N4O4 · H2O4S · 2H2O
782.94
Quinidine Sulfate Dihydrate (Quinine Sulfate Impurity A) RBPL-Q0301 6591-63-5
C40H48N4O4 · H2O4S · 2H2O;
782.94
ROXITHROMYCIN RBPL-R0100 80214-83-1 C41H76N2O15; 837.05
N,N-didesmethyl Roxithromycin RBPL-R0101 231620-65-8 C39H72N2O15; 809
Roxithromycin Impurity F (N-Desmethyl Roxithromycin)
(Roxithromycin Related Compound F)
RBPL-R0102 118267-18-8 C40H74N2O15; 823.02
Roxithromycin Impurity B RBPL-R0103 214902-82-6 C₃₃H₆₂N₂O₁₂; 678.85
Roxithromycin N-Oxide RBPL-R0105 1460313-73-8 C41H76N2O16; 853.06
Roxithromycin Impurity C (Erythromycin 9-Oxime Impurity)
(Clarithromycin Impurity J) (Azithromycin Impurity S)
RBPL-R0106 13127-18-9 C₃₇H₆₈N₂O₁₃; 748.94
RABEPRAZOLE RBPL-R0200 117976-89-3 C18H21N3O3S, 359.44
Rabeprazole Impurity I (Rabeprazole Sulfone N-Oxide) RBPL-R0201 924663-37-6 C18H21N3O5S; 391.44
Rabeprazole Impurity A (Rabeprazole Sulphone)
(Rabeprazole Related Compound D)
RBPL-R0202 117976-47-3 C18H21N3O4S; 375.44
Rabeprazole Impurity B (Rabeprazole Sulfide)
(Rabeprazole Related Compound E)
RBPL-R0203 117977-21-6 C₁₈H₂₁N₃O₂S; 343.44
Rabeprazole Impurity F (Rabeprazole Related Compound C)
(Lansoprazole Impurity E)
RBPL-R0205 583-39-1 C₇H₆N₂S; 150.2
RAMIPRIL RBPL-R0300 87333-19-5 C23H32N2O5. 416.51
Ramipril Impurity D (Ramipril Related Compound D) RBPL-R0301 108731-95-9 C23H30N2O4; 398.5
Ramipril Impurity B (Ramipril Related Compound B) RBPL-R0302 295328-72-2 C₂₄H₃₄N₂O₅; 430.54
Ramipril Impurity A (Ramipril Related Compound A)
(Ramipril Methyl Ester)
RBPL-R0306 108313-11-7 C22H30N2O5;402.49
RISPERIDONE RBPL-R0400 106266-06-2 C23H27FN4O2; 410.48
Risperidone Impurity C (9-OH Risperidone) RBPL-R0401 144598-75-4 C23H27FN4O3; 426.48
Risperidone-N-oxide (Risperidone Cis) RBPL-R0402 832747-55-4 C23H27FN4O3; 426.48
Risperidone Impurity E RBPL-R0403 1346602-28-5 C₂₄H₂₉FN₄O₂; 424.51
Risperidone-N-oxide (Trans) RBPL-R0404 NA C23H27FN4O3; 426.48
RANITIDINE RBPL-R0500 66357-35-5 C13H22N4O3S, 314.41
Ranitidine Impurity B RBPL-R0501 66356-53-4 C10H18N2OS; 214.33
Ranitidine-N-oxide RBPL-R0502 73857-20-2 C₁₃H₂₂N₄O₄S; 330.4
ROSUVASTATIN Calcium RBPL-R0700 147098-20-2 C22H27FN3O6S·½Ca; 500.57
Rosuvastatin lactone (Rosuvastatin Impurity-D) RBPL-R0701 503610-43-3 C₂₂H₂₆FN₃O₅; 463.52
RALOXIFENE RBPL-R0800 84449-90-1 C28H27NO4S, 473.58
Raloxifene Related Compound C (Raloxifene N-Oxide) RBPL-R0801 195454-31-0 C₂₈H₂₇NO₅S; 489.58
RANOLAZINE RBPL-R0900 95635-55-5 C24H33N3O4; 427.54
Ranolazine-N-oxide (Impurity 11) RBPL-R0901 NA C24H33N3O5; 443.55
Ranolazine-Bis N-oxide RBPL-R0902 1246816-00-1 C₂₄H₃₃N₃O₆; 459.54
RIZATRIPTAN RBPL-R1000 145202-66-0 C22H25N5O2, 391.47
Rizatriptan N-Oxide (Rizatriptan Impurity H) RBPL-R1001 260435-42-5 C15H19N5O; 285.35
SILDENAFIL RBPL-S0100 171599-83-0 C22H30N6O4S; 474.6
N-desmethyl Sildenafil RBPL-S0101 139755-82-1 C21H28N6O4S; 460.58
Sildenafil Impurity B (Sildenafil N-oxide) RBPL-S0102 1094598-75-0 C22H30N6O5S; 490.58
Sildenafil Impurity D RBPL-S0103 1357931-55-5 C17H20N4O5S ; 392.43
SOLIFENACIN RBPL-S0200 242478-38-2 C23H26N2O2; 362.473
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 14 of 16 
 
Solifenacin Impurity I (Solifenacin N-oxide) RBPL-S0201 180272-28-0 C₂₃H₂₆N₂O₃; 378.46
Solifenacin Impurity A RBPL-S0202 118864-75-8 C₁₅H₁₅N ; 209.29
Solifenacin Impurity E RBPL-S0203 25333-42-0 C7H13NO; 127.19
SERTRALINE RBPL-S0300 79617-96-2 C17H17Cl2N ; 306.23
Sertraline Impurity B (Sertraline Impurity-3) RBPL-S0302 52758-05-1 C17H20ClN; 273.80
Sertraline Impurity D (Sertraline Impurity-1) RBPL-S0304 871838-58-3 C17H18ClN ; 271.78
Sertraline Impurity C (Sertraline Impurity-2) RBPL-S0307 79646-00-7 C17H19ClN; 271.78
SULFASALAZINE RBPL-S0400 599-79-1 C18H14N4O5S; 398.394
Sulfasalazine Impurity D RBPL-S0401 66364-70-3 C17H14N4O3S; 354.38306
SIMVASTATIN RBPL-S0600 79902-63-9 C25H38O5; 418.56
Simvastatin Impurity C (Anhydro Simvastatin) RBPL-S0602 210980-68-0 C25H36O4; 400.56
Simvastatin Impurity F (Epi Lovastatin) RBPL-S0603 79952-44-6 C₂₄H₃₆O₅; 404.54
Simvastatin Impurity A (Simvastatin Related Compound A)
(Simvastatin Hydroxy Acid)
RBPL-S0604 530112-57-3 C50H80CaO13; 929.26
SUMATRIPTAN RBPL-S0800 103628-46-2 C14H21N3O2S; 295.402
Sumatriptan N-oxide (Sumatriptan Impurity D) RBPL-S0801 212069-94-8 C₁₄H₂₁N₃O₃S; 311.4
SITAGLIPTIN RBPL-S0900 486460-32-6 C16H15F6N5O, 407.31
Sitagliptin Impurity A RBPL-S0901 823817-58-9 C₁₆H₁5F₆N₅O; 407.32
Sitagliptin Impurity B RBPL-S0902 1345822-87-8 C₁₆H16F₅N₅O; 389.33
Sitagliptin Impurity C RBPL-S0903 1345822-86-7 C₁₆H₁6F₅N₅O; 389.31
Sitagliptin fumarate adduct (Sitagliptin Impurity-A) RBPL-S0904 2088771-60-0 C20H19F6N5O5 ; 523.39
SORAFENIB RBPL-S1000 284461-73-0 C21H16ClF3N4O3; 464.82
Sorafenib N-Oxide RBPL-S1001 583840-03-3 C21H16ClF3N4O; 480.82
SULFAMETHOXAZOLE RBPL-S1400 723-46-6 C10H11N3O3S; 253.28
Sulfamethoxazole Impurity F RBPL-S1401 17103-52-5 C10H11N3O3S; 253.28
SODIUM STEARYL RBPL-S1500 4070-80-8 C22H39NaO4; 390.54
Sodium Stearyl Fumarate SSF 4070-80-8 C22H39NaO4; 390.54
Sodium Stearyl Maleate SSM 5373-51-3 C22H39NaO4; 390.53
Monostearyl Maleate MSM 2424-62-2 C22H40O4; 368.55
SULINDAC RBPL-S1600
Sulindac Methyl Ester RBPL-S1603 134439-52-4 C21H19FO3S; 370.44
Sulindac Ethyl Ester RBPL-S1604 68299-97-8 C22H21FO3S; 384.46
Sulindac Isopropyl Ester RBPL-S1605 NA C23H23FO3S; 398.49
SULFADIAZINE RBPL-S1700 68-35-9 C10H10N4O2S; 250.28
SULFAQUINOXALINE SODIUM RBPL-S1800 967-80-6 C14H11N4NaO2S322.32
TELMISARTAN RBPL-T0100 144701-48-4 C33H30N4O2 514.62
Telmisartan Impurity F RBPL-T0101 915124-86-6 C₃₃H₃₁N₅O; 513.63
Telmisatran Impurity A (Telmisatran Related Compound A) RBPL-T0102 152628-02-9 C₁₉H₂₀N₄; 304.39
Telmisatran Impurity D RBPL-T0103 NA C26H24N2O4; 428.29
Telmisartan Methyl Ester RBPL-T0104 528560-93-2 C34H32N4O2 ; 528.6
Telmisartan Impurity B (Telmisatran Related Compound B) RBPL-T0105 1026353-20-7 C33H30N4O2; 514.62
TRAMADOL RBPL-T0200 27203-92-5 C16H25NO2; 263.38
Tramadol-N-oxide RBPL-T0201 147441-56-3 C16H25NO3; 279.37
Tramadol Impurity A (Tramadol Related Compound A) RBPL-T0202
2914-77-2; 152538-36-8
(FB); 73806-49-2
C16 H25NO2.ClH; 299.84
Tramadol Impurity D RBPL-T0203
NA; 185453-02-5 HCl;
80456-81-1 (FB)
C15H23NO2.HCl; 249.36 ; 285.82
HCl
Tramadol Impurity C RBPL-T0204
66170-31-8; 905592-54-3
(FB)
C16H23NO; 245.37
Tramadol Impurity E (Tramadol Related Compound B) RBPL-T0205 42036-65-7 C9H18ClNO
THIOCHOLCHICOSIDE RBPL-T0300 602-41-5 C27H33NO10S; 563.62
N-deacetyl-N-formyl Thiocholchicoside RBPL-T0302 219547-29-2 C26H31NO10S; 549.59
N-deacetyl-3-demethyl Thiocholchicine RBPL-T0303 97043-09-9 C19H21NO4S; 359.44
3-o-desmethyl Thiocholchicocine (Impurity C) RBPL-T0305 87424-25-7 C₂1H23NO5S; 401.48
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 15 of 16 
 
TROSPIUM RBPL-T0400 10405-02-4 C25H30ClNO3; 427.96
Trospium chloride Related Compound A (Trospium Impurity A) RBPL-T0401 76-93-7 C14H12O3; 228.24
Trospium Impurity D RBPL-T0402 467-32-3 C28H20O4; 420.45
TIMOLOL RBPL-T0600 26839-75-8 C13H24N4O3S; 316.421
Timolol Impurity D (Timolol Related Compound D) RBPL-T0601 30165-97-0 C6H9N3O2S; 187.22
Timolol Impurity B (Timolol Related Compound B) RBPL-T0602 158636-96-5 C13H24N4O3S; 316.43
Timolol Impurity A (Timolol Related Compound A) RBPL-T0603 26839-76-9 C13H24N4O3S; 316.42
TOLTERODINE RBPL-T0700 124937-51-5 C22H31NO; 325.49
Tolterodine Lactone RBPL-T0701 40546-94-9 C₁₆H₁₄O₂; 238.28
TAMSULOSIN RBPL-T0800 106133-20-4 C20H28N2O5S; 408.5117
Tamsulosin Impurity D RBPL-T0801 80223-96-7 C19H26N2O5S ; 394.49
Tamsulosin HCl Impurity G RBPL-T0802 80223-99-0; 106463-19-8 C₂₀H₂₉ClN₂O₅S; 444.97
Tamsulosin Impurity H RBPL-T0803 1329611-47-3 C20H27NO3; 329.43
Tamsulosin Impurity A RBPL-T0804 918867-88-6 C₃₀H₄₀N₂O₇S; 572.71
Tamsulosin Impurity B RBPL-T0805 112101-81-2 C10H16N2O3S; 244.31
Tamsulosin Impurity C RBPL-T0806 NA C18H24N2O4S.HCl; 364.45 36.5
TAMOXIFEN RBPL-T0900 10540-29-1 C26H29NO; 371.52
Tamoxifen-N-oxide RBPL-T0901 75504-34-6 C26H29NO2; 387.51
N-Desmethyl Tamoxifen Hcl RBPL-T0902 31750-48-8 C25H27NO; 357.49
TIZANIDINE RBPL-T1400 51322-75-9 C9H8ClN5S 253.71
Tizanidine Impurity A RBPL-T1401 51322-69-1 C9H9N5S; 219.27
Tizanidine Impurity B RBPL-T1402 51323-05-8 C₇H₅ClN₄S₂; 244.72
Tizanidine Impurity C RBPL-T1403 1147548-83-1 C16H14Cl2N10S2; 481.39
Tizanidine Impurity D RBPL-T1404 51323-03-6 C8H7CIN4S2; 258.75
Tizanidine Impurity E (Tizanidine Related Compound A) RBPL-T1405 30536-19-7 C6H4ClN3S; 185.63
Tizanidine Impurity F RBPL-T1406 1147548-85-3 C₁₆H₁₁Cl₂N₉S₂; 464.35
TRANEXAMIC ACID RBPL-T1500
Tranexamic acid RBPL-T1500 1197-18-8 C8H15NO2;157.21
Tranexamic acid Impurity D RBPL-T1501 56-91-7 C8H9NO2;151.16
TERBUTALINE RBPL-T1600
Terbutaline Sulphate Impurity C RBPL-T1601
139508-58-0 (Free base)
1246815-70-2 (HCl salt)
C₁₂H₁₈ClNO₃; 259.73
TOFACITINIB RBPL-T1800 477600-75-2 C16H20N6O; 312.38
Tofacitinib pyrimidine N-oxide RBPL-T1801 2028267-73-2 C16H20N6O2 328.38
Tofacitinib pyrimidine N-oxide (Impurity 2) RBPL-T1802 NA C16H20N6O2 ; 328.37
TAPENTADOL RBPL-T2200 175591-09-0 C14H23NO·HCl; 257.80
Tapentadol N-Oxide RBPL-T2201 1346601-17-9 C14H23NO2; 237.34
TRIMETHOPRIM RBPL-T2400 738-70-5 C14H18N4O3; 290.32
Trimethoprim N-Oxide RBPL-T2401 27653-67-4 C14H18N4O;4 306.31
Trimethoprim N-Oxide RBPL-T2402 27653-68-5 C14H18N4O4; 306.32
Trimethoprim N,N-di-N-Oxide RBPL-T2403
TETRACYCLINE RBPL-T2500 60-54-8 C22H24N2O8; 444.43
Tetracycline Impurity D (4-Epianhydrotetracycline
hydrochloride)
RBPL-T2501 4465-65-0 C₂₂H₂₃ClN₂O₇;462.88
TIOTROPIUM RBPL-T2600 136310-93-5 C19H22BrNO4S2; 472.42
Tiotropium bromide Impurity G RBPL-T2601 1508-46-9 C9H16NBrO2; 250.13
THEOBROMINE RBPL-T2700 83-67-0 C7H8N4O2; 180.16
VERAPAMIL RBPL-V0100 52-53-9 C27H38N2O4; 454.602
Verapamil Impurity K RBPL-V0102 20850-49-1 C13H17NO2; 219.29
VENLAFAXINE RBPL-V0200 93413-69-5 C17H27NO2. 277.40
Desvenlafaxine succinate (O-Desmethyl Venlafaxine) RBPL-V0201
93413-62-8;
386750-22-7
C₁₆H₂₅NO₂; 263.38
Venlafaxine Impurity F RBPL-V0202
93413-79-7(Hcl)
93413-57-1(FB)
C17H26ClNO; 295.85(Hcl)
259.4(FB)
 
REFSYN BIOSCIENCES PRIVATE LIMITED 
PUDUCHERRY 
Refsyn In‐stock API Impurities List (2021‐2022) 
COMPOUND NAME PRODUCT CODE CAS NO. MF/MW
Page 16 of 16 
 
Venlafaxine Impurity B RBPL-V0203 323176-93-8 (base) C14H21NO3 (base); 251.32
Venlafaxine N-oxide RBPL-V0204 1021933-95-8 C₁₆H₂₅NO₃; 279.37
VALSARTAN RBPL-V0300 137862-53-4 C24H29N5O3; 435.52
Valsartan Methyl ester (Valsartan Related Compound E) RBPL-V0301 137863-17-3 C₂₅H₃₁N₅O₃; 449.55
Valsartan Isopropyl ester RBPL-V0302 1245820-09-0 C₂₇H₃₅N₅O₃; 477.6
Valsartan Ethyl ester RBPL-V0303 1111177-30-0 C₂₆H₃₃N₅O₃; 463.57
Valsartan Impurity C (Valsartan Related Compound B) RBPL-V0305 952652-79-8 C23H27N5O3; 421.49
VALPROIC ACID RBPL-V0400
1069-66-5Free acid:
99-66-1
C₈H₁₅NaO₂; 166.19
Valproic acid Related Compound A RBPL-V0403 99-67-2 C8H12O2 ; 140.18
VARDENAFIL RBPL-V0800 224785-90-4 C23H32N6O4S; 488.6
Vardenafil N-Oxide (Vardenafil Related Compound D) RBPL-V0801 448184-48-3 C₂₃H₃₂N₆O₅S; 504.6
VILDAGLIPTIN RBPL-V0900 274901-16-5 C17H25N3O2; 303.40
Vildagliptin Amide RBPL-V0902 565453-39-6 C₁₇H₂₇N₃O₃; 321.41
ZIDOVUDINE RBPL-Z0100 30516-87-1 C10H13N5O4; 267.24
Zidovudine Impurity B (Zidovudine Related Compound B) RBPL-Z0101 25526-94-7 C10H13ClN2O4; 260.67
ZIPRASIDONE RBPL-Z0200 146939-27-7 C21H21ClN4OS; 412.94
Ziprasidone Related Compound B RBPL-Z0201 1159977-56-6 C₂₁H₁₉ClN₄O₂S; 426.92
Ziprasidone Impurity E (Ziprasidone Related Compound D) RBPL-Z0202 1159977-04-4 C₂₈H₂₄ClN₅OS₂;546.11
Ziprasidone Impurity C (Ziprasidone Related Compound F)
(Open Ring)
RBPL-Z0203 1159977-64-6 C21H23ClN4O2S; 430.95
Ziprasidone Deschloro Impurity RBPL-Z0204 118305-72-9 C21H22N4OS; 378.5
Ziprasidone N-Oxide RBPL-Z0205 188797-76-4 C₂₁H₂₁ClN₄O₂S; 428.94
Ziprasidone S-Oxide RBPL-Z0206 188797-80-0 C₂₁H₂₁ClN₄O₂S; 428.94
 

More Related Content

Similar to Refsyn product list (2022-23)

Product list specialty reagents
Product list specialty reagentsProduct list specialty reagents
Product list specialty reagentsSwissHuge
 
LISINOPRIL Impurities Manufacturer | Suppliers | Hemarsh Technologies
LISINOPRIL Impurities Manufacturer | Suppliers | Hemarsh TechnologiesLISINOPRIL Impurities Manufacturer | Suppliers | Hemarsh Technologies
LISINOPRIL Impurities Manufacturer | Suppliers | Hemarsh TechnologiesHemarsh Technologies
 
Applichem lista de reagentes 2014
Applichem lista de reagentes 2014Applichem lista de reagentes 2014
Applichem lista de reagentes 2014AnaVanz
 
SACUBITRIL Impurities Manufacturer | Suppliers | Hemarsh Technologies
SACUBITRIL Impurities Manufacturer | Suppliers | Hemarsh TechnologiesSACUBITRIL Impurities Manufacturer | Suppliers | Hemarsh Technologies
SACUBITRIL Impurities Manufacturer | Suppliers | Hemarsh TechnologiesHemarsh Technologies
 
BD_FGases_19_12_2019.pdf
BD_FGases_19_12_2019.pdfBD_FGases_19_12_2019.pdf
BD_FGases_19_12_2019.pdfhafp hafp
 
Atorvastatin Impurities | India | Hemarsh Technologies
Atorvastatin Impurities | India | Hemarsh TechnologiesAtorvastatin Impurities | India | Hemarsh Technologies
Atorvastatin Impurities | India | Hemarsh TechnologiesHemarsh Technologies
 
Ark boronic acids & esters brochures
Ark boronic acids & esters brochuresArk boronic acids & esters brochures
Ark boronic acids & esters brochuresJuanAguilar266
 
Power plant performance_efficiency
Power plant performance_efficiencyPower plant performance_efficiency
Power plant performance_efficiencyKeyur Patel
 

Similar to Refsyn product list (2022-23) (12)

ICAMA List by Fengshan
ICAMA  List by FengshanICAMA  List by Fengshan
ICAMA List by Fengshan
 
Product list specialty reagents
Product list specialty reagentsProduct list specialty reagents
Product list specialty reagents
 
LISINOPRIL Impurities Manufacturer | Suppliers | Hemarsh Technologies
LISINOPRIL Impurities Manufacturer | Suppliers | Hemarsh TechnologiesLISINOPRIL Impurities Manufacturer | Suppliers | Hemarsh Technologies
LISINOPRIL Impurities Manufacturer | Suppliers | Hemarsh Technologies
 
product list
product listproduct list
product list
 
Applichem lista de reagentes 2014
Applichem lista de reagentes 2014Applichem lista de reagentes 2014
Applichem lista de reagentes 2014
 
SACUBITRIL Impurities Manufacturer | Suppliers | Hemarsh Technologies
SACUBITRIL Impurities Manufacturer | Suppliers | Hemarsh TechnologiesSACUBITRIL Impurities Manufacturer | Suppliers | Hemarsh Technologies
SACUBITRIL Impurities Manufacturer | Suppliers | Hemarsh Technologies
 
BD_FGases_19_12_2019.pdf
BD_FGases_19_12_2019.pdfBD_FGases_19_12_2019.pdf
BD_FGases_19_12_2019.pdf
 
Session 4.1 Pessin
Session 4.1 PessinSession 4.1 Pessin
Session 4.1 Pessin
 
Session 4.1: Pessin
Session 4.1: PessinSession 4.1: Pessin
Session 4.1: Pessin
 
Atorvastatin Impurities | India | Hemarsh Technologies
Atorvastatin Impurities | India | Hemarsh TechnologiesAtorvastatin Impurities | India | Hemarsh Technologies
Atorvastatin Impurities | India | Hemarsh Technologies
 
Ark boronic acids & esters brochures
Ark boronic acids & esters brochuresArk boronic acids & esters brochures
Ark boronic acids & esters brochures
 
Power plant performance_efficiency
Power plant performance_efficiencyPower plant performance_efficiency
Power plant performance_efficiency
 

Recently uploaded

Moradia Isolada com Logradouro; Detached house with patio in Penacova
Moradia Isolada com Logradouro; Detached house with patio in PenacovaMoradia Isolada com Logradouro; Detached house with patio in Penacova
Moradia Isolada com Logradouro; Detached house with patio in Penacovaimostorept
 
Falcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow ChallengesFalcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow Challengeshemanthkumar470700
 
A DAY IN THE LIFE OF A SALESPERSON .pptx
A DAY IN THE LIFE OF A SALESPERSON .pptxA DAY IN THE LIFE OF A SALESPERSON .pptx
A DAY IN THE LIFE OF A SALESPERSON .pptxseemajojo02
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistanvineshkumarsajnani12
 
Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024Marel
 
Ital Liptz - all about Itai Liptz. news.
Ital Liptz - all about Itai Liptz. news.Ital Liptz - all about Itai Liptz. news.
Ital Liptz - all about Itai Liptz. news.htj82vpw
 
Jual obat aborsi Hongkong ( 085657271886 ) Cytote pil telat bulan penggugur k...
Jual obat aborsi Hongkong ( 085657271886 ) Cytote pil telat bulan penggugur k...Jual obat aborsi Hongkong ( 085657271886 ) Cytote pil telat bulan penggugur k...
Jual obat aborsi Hongkong ( 085657271886 ) Cytote pil telat bulan penggugur k...Klinik kandungan
 
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptxQSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptxDitasDelaCruz
 
2024 May - Clearbit Integration with Hubspot - Greenville HUG.pptx
2024 May - Clearbit Integration with Hubspot  - Greenville HUG.pptx2024 May - Clearbit Integration with Hubspot  - Greenville HUG.pptx
2024 May - Clearbit Integration with Hubspot - Greenville HUG.pptxBoundify
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxCynthia Clay
 
JIND CALL GIRL ❤ 8272964427❤ CALL GIRLS IN JIND ESCORTS SERVICE PROVIDE
JIND CALL GIRL ❤ 8272964427❤ CALL GIRLS IN JIND ESCORTS SERVICE PROVIDEJIND CALL GIRL ❤ 8272964427❤ CALL GIRLS IN JIND ESCORTS SERVICE PROVIDE
JIND CALL GIRL ❤ 8272964427❤ CALL GIRLS IN JIND ESCORTS SERVICE PROVIDEkajalroy875762
 
Falcon Invoice Discounting: Empowering Your Business Growth
Falcon Invoice Discounting: Empowering Your Business GrowthFalcon Invoice Discounting: Empowering Your Business Growth
Falcon Invoice Discounting: Empowering Your Business GrowthFalcon investment
 
UJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDE
UJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDEUJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDE
UJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDEkajalroy875762
 
Abortion pills in Jeddah ! +27737758557, cytotec pill riyadh. Saudi Arabia" A...
Abortion pills in Jeddah ! +27737758557, cytotec pill riyadh. Saudi Arabia" A...Abortion pills in Jeddah ! +27737758557, cytotec pill riyadh. Saudi Arabia" A...
Abortion pills in Jeddah ! +27737758557, cytotec pill riyadh. Saudi Arabia" A...bleessingsbender
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting
 
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...ssuserf63bd7
 
The Art of Decision-Making: Navigating Complexity and Uncertainty
The Art of Decision-Making: Navigating Complexity and UncertaintyThe Art of Decision-Making: Navigating Complexity and Uncertainty
The Art of Decision-Making: Navigating Complexity and Uncertaintycapivisgroup
 
The Vietnam Believer Newsletter_May 13th, 2024_ENVol. 007.pdf
The Vietnam Believer Newsletter_May 13th, 2024_ENVol. 007.pdfThe Vietnam Believer Newsletter_May 13th, 2024_ENVol. 007.pdf
The Vietnam Believer Newsletter_May 13th, 2024_ENVol. 007.pdfbelieveminhh
 
Shots fired Budget Presentation.pdf12312
Shots fired Budget Presentation.pdf12312Shots fired Budget Presentation.pdf12312
Shots fired Budget Presentation.pdf12312LR1709MUSIC
 

Recently uploaded (20)

Moradia Isolada com Logradouro; Detached house with patio in Penacova
Moradia Isolada com Logradouro; Detached house with patio in PenacovaMoradia Isolada com Logradouro; Detached house with patio in Penacova
Moradia Isolada com Logradouro; Detached house with patio in Penacova
 
Falcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow ChallengesFalcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow Challenges
 
A DAY IN THE LIFE OF A SALESPERSON .pptx
A DAY IN THE LIFE OF A SALESPERSON .pptxA DAY IN THE LIFE OF A SALESPERSON .pptx
A DAY IN THE LIFE OF A SALESPERSON .pptx
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
 
Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024
 
Ital Liptz - all about Itai Liptz. news.
Ital Liptz - all about Itai Liptz. news.Ital Liptz - all about Itai Liptz. news.
Ital Liptz - all about Itai Liptz. news.
 
Jual obat aborsi Hongkong ( 085657271886 ) Cytote pil telat bulan penggugur k...
Jual obat aborsi Hongkong ( 085657271886 ) Cytote pil telat bulan penggugur k...Jual obat aborsi Hongkong ( 085657271886 ) Cytote pil telat bulan penggugur k...
Jual obat aborsi Hongkong ( 085657271886 ) Cytote pil telat bulan penggugur k...
 
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptxQSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
QSM Chap 10 Service Culture in Tourism and Hospitality Industry.pptx
 
2024 May - Clearbit Integration with Hubspot - Greenville HUG.pptx
2024 May - Clearbit Integration with Hubspot  - Greenville HUG.pptx2024 May - Clearbit Integration with Hubspot  - Greenville HUG.pptx
2024 May - Clearbit Integration with Hubspot - Greenville HUG.pptx
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
 
JIND CALL GIRL ❤ 8272964427❤ CALL GIRLS IN JIND ESCORTS SERVICE PROVIDE
JIND CALL GIRL ❤ 8272964427❤ CALL GIRLS IN JIND ESCORTS SERVICE PROVIDEJIND CALL GIRL ❤ 8272964427❤ CALL GIRLS IN JIND ESCORTS SERVICE PROVIDE
JIND CALL GIRL ❤ 8272964427❤ CALL GIRLS IN JIND ESCORTS SERVICE PROVIDE
 
Falcon Invoice Discounting: Empowering Your Business Growth
Falcon Invoice Discounting: Empowering Your Business GrowthFalcon Invoice Discounting: Empowering Your Business Growth
Falcon Invoice Discounting: Empowering Your Business Growth
 
UJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDE
UJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDEUJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDE
UJJAIN CALL GIRL ❤ 8272964427❤ CALL GIRLS IN UJJAIN ESCORTS SERVICE PROVIDE
 
Abortion pills in Jeddah ! +27737758557, cytotec pill riyadh. Saudi Arabia" A...
Abortion pills in Jeddah ! +27737758557, cytotec pill riyadh. Saudi Arabia" A...Abortion pills in Jeddah ! +27737758557, cytotec pill riyadh. Saudi Arabia" A...
Abortion pills in Jeddah ! +27737758557, cytotec pill riyadh. Saudi Arabia" A...
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
 
Buy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail AccountsBuy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail Accounts
 
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
 
The Art of Decision-Making: Navigating Complexity and Uncertainty
The Art of Decision-Making: Navigating Complexity and UncertaintyThe Art of Decision-Making: Navigating Complexity and Uncertainty
The Art of Decision-Making: Navigating Complexity and Uncertainty
 
The Vietnam Believer Newsletter_May 13th, 2024_ENVol. 007.pdf
The Vietnam Believer Newsletter_May 13th, 2024_ENVol. 007.pdfThe Vietnam Believer Newsletter_May 13th, 2024_ENVol. 007.pdf
The Vietnam Believer Newsletter_May 13th, 2024_ENVol. 007.pdf
 
Shots fired Budget Presentation.pdf12312
Shots fired Budget Presentation.pdf12312Shots fired Budget Presentation.pdf12312
Shots fired Budget Presentation.pdf12312
 

Refsyn product list (2022-23)

  • 1. REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2022-23)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 1 of 16  ACECLOFENAC  RBPL-A0100 89796-99-6 C16H13Cl2NO4; 354.18 Aceclofenac Impurity A (Diclofenac Free Acid) (Diclofemac Sodium) (Diclofenac Impurity K) RBPL-A0101 15307-86-5 (Free acid); 15307-79-6(Na) 15307-81-0(K) C14H10Cl2NNaO2; 318.13 C14H11Cl2NO2 296.14 (FA) Aceclofenac Impurity B (Diclofenac Methyl Ester) RBPL-A0102 15307-78-5; C15H13Cl2NO2; 310.18 Aceclofenac Impurity I (Aceclofenac Related Compound A) (Diclofenac Amide) (Diclofenac Impurity A) (Diclofenac Related Compound A) (Diclofenac Lactum Impurity) RBPL-A0103 15362-40-0 C14H9Cl2NO; 278.13 Aceclofenac Impurity E (Aceclofenac Ethyl Ester) RBPL-A0104 139272-67-6 C18H17Cl2NO4; 382.24 Aceclofenac Impurity D (Aceclofenac Methyl Ester) RBPL-A0105 139272-66-5; C17H15Cl2NO4; 368.21 Aceclofenac Impurity F (Aceclofenac Benzyl Ester) RBPL-A0106 100499-89-6 C23H19Cl2NO4; 444.31 Aceclofenac Impurity G RBPL-A0107 1215709-75-3 C18H15Cl2NO6; 412.22 AZITHROMYCIN RBPL-A0200 83905-01-5 C38H72N2O12, 748.98 Azithromycin Impurity E RBPL-A0201 612069-27-9 C36H68N2O12; 720.93 Azithromycin Impurity F (Azithromycin Related Compound F) RBPL-A0202 612069-28-0 C38H70N2O13; 762.97 Azithromycin Impurity I RBPL-A0203 172617-84-4 C37H70N2O12; 734.96 Azithromycin Impurity L (Azithromycin N-oxide) RBPL-A0204 90503-06-3 C38H72N2O13; 764.98 Azithromycin Impurity M RBPL-A0206 765927-71-7 C37H68N2O13; 748.94 Azithromycin Impurity N RBPL-A0207 612069-25-7 C₃₆H₆₅NO₁₃; 719.9 Azithromycin Impurity A (Azaerythromycin ) (Azithromycin Related Compound A) RBPL-A0208 76801-85-9 C37H70N2O12; 734.96 Azithromycin Impurity J (Desosaminyl azithromycin) RBPL-A0209 117693-41-1 C30H58N2O9; 590.79 Azithromycin Impurity S (Clarithromycin Impurity J) (Erythromycin-9-oxime) (Roxithromycin Impurity C) RBPL-A02 13127-18-9 C₃₇H₆₈N₂O₁₃; 748.94 ALBENDAZOLE RBPL-A0300 54965-21-8 C12H15N3O2S 265.33 Albendazole Impurity C (Albendazole Sulphone) RBPL-A0301 75184-71-3 C12H15N3O4S; 297.33 Albendazole Impurity B (Albendazole S-oxide) RBPL-A0302 54029-12-8 C12H15N3O3S; 281.33 Albendazole Impurity D (Amino Albendazole Sulfone) RBPL-A0303 80983-34-2 C10H13N3O2S; 239.29 Albendazole Impurity A (Amino Albendazole) RBPL-A0305 80983-36-4 C10H13N3S; 207.3 ACEBUTOLOL RBPL-A0400 37517-30-9 C18H28N2O4; 336.42 Acebutolol Impurity C (Acebutolol Related Compound A) RBPL-A0401 40188-45-2 C12H15NO3; 221.25 Acebutolol Impurity J RBPL-A0402 57898-79-0 C17H27ClN2O4; 358. AZELASTINE RBPL-A0500 58581-89-8 C22H24ClN3O, 381.90 Azelastine Impurity A RBPL-A0501 613-94-5 C7H8N2O; 136.15 ABIRATERONE ACETATE RBPL-A0600 154229-18-2 C26H33NO2; 391.55 Abiraterone RBPL-A0603 154229-19-3 C₂₄H₃₁NO; 349.51 3-Keto Abiraterone RBPL-A0604 154229-21-7 C24H29NO; 347.49 Abiraterone N, N-dioxide RBPL-A0605 2378463-76-2 C24H31NO2; 365.5 ATORVASTATIN RBPL-A0800 Free Acid: 134523-00-5 134523-03-8 C₆₆H₆₈CaF₂N₄O₁₀; 1155.34 Atorvastatin Impurity H (Atorvastatin Lactone) (Atorvastatin Related Compound H) RBPL-A0801 125995-03-1 C33H33FN2O4; 540.62 o-OH Atorvastatin lactone RBPL-A0802 163217-74-1 C₃₃H₃₃FN₂O₅; 556.62 p-OH Atorvastatin lactone RBPL-A0803 163217-70-7 C₃₃H₃₃FN₂O₅; 556.62 Atovastatin Impurity D (Atorvastatin Related Compound D) RBPL-A0804 148146-51-4 C26H22FNO4; 431.46 Atovastatin Impuity C (Atorvastatin Related Compound C) (Difluoro Atorvastatin) RBPL-A0805 693793-53-2(ca salt); 693794-20-6 (FB) C66H68CaF2N4O10; 1191.3; C33H34F2N2O5; 576.63 Atovastatin Impurity A (Atorvastatin Related Compound A) (Desfluoro Atorvastatin) RBPL-A0806 433289-83-9 (Calcium salt) C33H35CaN2O5+; 579.7194 Atovastatin Impurity B (Atorvastatin Related Compound B) RBPL-A0807 N/A C33H34N2O51/2Ca; 557.63 Atovastatin Related Compound E RBPL-A0808 501121-34-2 (free acid) C33H34N2NaO5; 557.63 Atorvastatin Methyl Ester RBPL-A0810 345891-62-5 C34H37FN2O5; 572.67 ASPIRIN RBPL-A0900 50-78-2 C₉H₈O₄; 180.16
  • 2.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 2 of 16    Aspirin Impurity E RBPL-A0901 552-94-3 C14H10O5; 258.23 Aspirin Impurity F RBPL-A0902 1466-82-6 C18H14O7; 342.3 Aspirin Impurity C RBPL-A0905 69-72-7 C₇H₆O₃; 138.12 AMOXICILLIN RBPL-A1000 26787-78-0 C16H19N3O5S; 365.40 Amoxicillin Impurity A (Amoxicillin Related Compound A) RBPL-A1001 551-16-6 C8H12N2O3S; 216.26 ARIPIPRAZOLE RBPL-A1100 129722-12-9 C23H27Cl2N3O2; 448.39 Aripiprazole Related Compound F (Aripiprazole N-oxide) RBPL-A1101 573691-09-5 C₂₃H₂₇Cl₂N₃O₃; 464.38 Aripiprazole-N,N'-dioxide RBPL-A1102 573691-13-1 C₂₃H₂₇Cl₂N₃O₄; 480.38 Aripiprazole Impurity A (Aripiprazole Related Compound A) RBPL-A1103 22246-18-0 C₉H₉NO₂; 163.17 ACETAZOLAMIDE RBPL-A1200 59-66-5 C4H6N4O3S2; 222.25 Acetazolamide Impurity A RBPL-A1201 60320-32-3 C₄H₄ClN₃OS; 177.61 Acetazolamide Impurity B RBPL-A1202 5393-55-2 C4H5N3OS; 143.17 Acetazolamide Impurity E RBPL-A1203 827026-60-8 (free acid) C4H5N3O4S2; 223.23 Acetazolamide Impurity C RBPL-A1204 32873-56-6 C₄H₅N₃OS₂; 175.23 AMLODIPINE RBPL-A1300 88150-42-9 C20H25ClN2O5; 408.88 Amlodipine Impurity A (Amlodipine Phthalimide) RBPL-A1301 88150-62-3 C₂₈H₂₇ClN₂O₇ ; 538.98 Amlodipine Impurity G RBPL-A1302 43067-01-2 C₁₇H₁₈ClNO₄; 335.78 Amlodipine Impurity E (Amlodipine Related Compound E) RBPL-A1303 140171-65-9 C₂₁H₂₇ClN₂O₅; 422.9 Amlodipine Besylate Related Compound A (Amlodipine Impurity D) RBPL-A1304 2138811-33-1(FB) 113994-41-5 C20H23ClN2O5. C4H4O4 ; 522.93 406.86 ALFUZOSIN RBPL-A1400 81403-80-7 C19H27N5O4, 389.45 Alfuzosin Impurity A RBPL-A1401 98902-29-5; 98902-36-4 (Base) C₁₉H₂₄ClN₅O₄; 421.88 ALLOPURINOL RBPL-A1500 315-30-0 C5H4N4O; 136.11 Allopurinol Impurity A RBPL-A1501 27511-79-1 C4H6N4O; 126.12 Allopurinol Impurity D (Allopurinol Related Compound D) RBPL-A1502 6994-25-8 C6H9N3O2; 155.15 ACICLOVIR RBPL-A1600 59277-89-3 C8H11N5O3; 225.20 Aciclovir Impurity I RBPL-A1603 1797832-75-7 C14H16N10O4 ; 388.35 ASENAPINE RBPL-A2000 65576-45-6 C₁₇H₁₆ClNO; 285.77 Asenapine Amide RBPL-A2001 NA C17H14ClNO2; 299.75 Asenapine Deschloro RBPL-A2002 NA C17H17NO; 251.33 Cis-Asenapine RBPL-A2003 65621-78-5 C17H16ClNO; 285.77 Asenapine-N-oxide RBPL-A2004 128949-51-9 C17H16ClNO2; 301.77 Asenapine N-Desmethyl RBPL-A2005 1170701-78-6 C16H15Cl2NO; 308.20 Asenapine Deschloro amide RBPL-A2006 NA C17H17NO; 251.33 AMIODARONE RBPL-A2100 1951-25-3 C₂₅H₂₉I₂NO₃645.31 Amiodarone N-Oxide (HCl) RBPL-A2101 318267-30-0 C25H29I2NO4 ; 661.30 Amiodarone Impurity B (Amiodarone Related Compound B) (Desethyl Amiodarone) RBPL-A2102 96027-74-6 (Hcl); freebase: 83409-32-9 C₂₃H₂₆ClI₂NO₃ ; 653.72 AMITRIPTYLINE RBPL-A2200 549-18-8 C20H24ClN; 313.9 Amitriptyline (Nortriptyline Impurity F) RBPL-A2200 50-48-6 (FB) C20H23N; 277.4 Amitriptyline N-Oxide (Nortriptyline Hydrochloride - Impurity J) RBPL-A2201 4317-14-0 C₂₀H₂₃NO ; 293.40 AMISULPRIDE RBPL-A2300 53583-79-2 C17H26N2O4S; 354.47 Amisulpride Impurity F (Amisulpride N-Oxide) RBPL-A2301 71676-01-2 C17H27N3O5S; 385.49 AFATINIB RBPL-A3200 439081-18-2 C₂₄H₂₅ClFN₅O₃; 485.94 Afatinib N-Oxide (Afatinib Impurity L) RBPL-A3201 NA C₂₄H₂₅ClFN₅O₄; 501.94 ATENOLOL RBPL-A3300 29122-68-7 C14H22N2O3; 266.34 ASPARTAME RBPL-A3500 22839-47-0 C14H18N2O5; 294.31 Aspartame Impurity B RBPL-A3501 13433-09-5 C13H16N2O5; 280.28 Aspartame Impurity C RBPL-A3502 63-91-2 C9H11NO2; 165.19 AMODIAQUINE HYDROCHLORIDE RBPL-A3900 6398-98-7 C20H22ClN3O·2HCl·2H2O; 464.81 BECLOMETHASONE RBPL-B0100 4419-39-0 C22H29ClO5, 408.92
  • 3.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 3 of 16    Beclomethasone Impurity R (Beclomethasone Dipropionate Impurity R) RBPL-B0101 NA C22H28O5; 372.47 Beclomethasone Impurity G RBPL-B0102 1186048-33-8 C31H41FO8; 560.65 Beclomethasone Impurity V RBPL-B0103 205105-83-5 C25H32O6; 428.52 BETAXOLOL RBPL-B0200 63659-18-7 C18H29NO3 · HCl; 343.89. Betaxolol HCl Impurity A RBPL-B0201 464877-45-0 C14H24ClNO2; 273.8; 237 (FB) Betaxolol HCl Impurity B RBPL-B0202 62572-94-5 C₁₄H₂₃NO₃; 253.34 BENDROFLUMETHIAZIDE RBPL-B0400 73-48-3 C15H14F3N3O4S2, 421.41 Bendroflumethiazide Impurity A RBPL-B0401 654-62-6 C₇H₈F₃N₃O₄S₂; 318.28 BRIMONIDINE RBPL-B0500 59803-98-4 Tartrate Salt: 59803-99-5 C₁₁H₁₀BrN₅; 292.13 Brimonidine Impurity A RBPL-B0501 91147-43-2 C11H11N5; 213.24 BORTEZOMIB RBPL-B0800 179324-69-7 C19H25BN4O4 384.24 Bortezomib Impurity B RBPL-B0801 114457-94-2 C₁₄H₁₃N₃O₃; 271.27 BENZOTHIADIAZINE RBPL-B1000 255-18-5 C7H6N2S; 150.2 Benzothiadiazine Related Compound A RBPL-B1001 121-30-2 C₆H₈ClN₃O₄S₂; 285.73 BIPERIDEN RBPL-B1200 514-65-8 C21H29NO; 311.4611 Biperiden N-Oxide (Lidocaine Impurity B) RBPL-B1201 2903-45-9 C₁₄H₂₂N₂O₂; 250.34 BROMHEXINE Hcl RBPL-B1400 611-75-6 (Hcl) C14H20Br2N2 · HCl; 412.59 Bromhexine N-oxide RBPL-B1401 NA C14H20Br2N2O; 392.14 BISACODYL RBPL-B1700 603-50-9 C22H19NO4; 361.391 CLARITHROMYCIN RBPL-C0100 81103-11-9 C38H69NO13; 747.95 14-Hydroxy Clarithromycin RBPL-C0101 116836-41-0 C38H69NO14; 763.95 Clarithromycin Impurity D (Clarithromycin Related Compound D) (N-Desmethyl Clarithromycin) RBPL-C0102 101666-68-6 C37H67NO13; 733.93 Clarithromycin Impurity Q (Clarithromycin N-oxide) (Clarithromycin Related Compound Q) RBPL-C0103 118074-07-0 C38H69NO14; 763.95 Clarithromycin Impurity I RBPL-C0104 118058-74-5 C30H55NO10; 589.76 Clarithromycin Impurity K RBPL-C0105 127157-35-1 C30H51NO8; 553.73 Clarithromycin Impurity L (Clarithromycin (9Z)-Oxime) RBPL-C0106 127253-05-8 C38H70N2O13; 762.97 Clarithromycin Impurity M RBPL-C0107 127182-43-8 C37H68N2O13; 748 Clarithromycin Impurity N RBPL-C0108 144604-03-5 C38H67NO12; 729.94 Clarithromycin Impurity C (Clarithromycin E-9-Oxime) RBPL-C0109 127253-06-9 C38H70N2O13; 762.97 Clarithromycin Impurity E (Related Compound A) RBPL-C0110 81103-14-2 C39H71NO13; 761.98 Clarithromycin Impurity J (Erythromycin-9-oxime) (Roxithromycin Impurity C) (Azithromycin Impurity S) RBPL-C0112 13127-18-9 C₃₇H₆₈N₂O₁₃; 748.94 Clarithromycin Impurity R RBPL-C0113 992-62-1 C36H65NO13; 719.9 CAPECITABINE RBPL-C0200 154361-50-9 C15H22FN3O6; 359.35 Capecitabine Related Compound C RBPL-C0201 921769-65-5 C₁₆H₂₀FN₃O₇; 385.34 CITALOPRAM RBPL-C0300 59729-33-8 C20H21FN2O; 324.392 Citalopram Hydrobromide RBPL-C0300 59729-32-7 C20H21FN2O·HBr; 405.31 Citalopram Impurity D RBPL-C0301 1188264-72-3 C19H20BrFN2O; 391.28 Citalopram N-oxide (Citalopram Related Compound E) RBPL-C0302 63284-72-0 C20H21FN2O2; 340.3913 Citalopram Impurity C (Citalopram Related Compound C) RBPL-C0303 372941-54-3 C₂₀H₁₉FN₂O₂; 338.38 Citalopram Impurity E RBPL-C0304 NA C19H22BrClFNO; 413.05 Citalopram Impurity G RBPL-C0305 1329745-98-3 (FB) C25H33FN2O2; 412.54 CLOPIDOGREL RBPL-C0400 113665-84-2 C16H16ClNO2S, 321.82 Clopidogrel Impurity A (Clopidogrel Related Compound A) RBPL-C0401 144750-42-5 (Hcl) C15H15Cl2NO2S; 344.26 Clopidogrel Impurity B (Clopidogrel Related Compound B) RBPL-C0402 144750-52-7 C₁₆H₁₇Cl₂NO₂S; 358.28 Clopidogrel Impurity C (Clopidogrel Related Compound C) RBPL-C0403 120202-71-3 C₁₆H₁₈ClNO₆S₂; 419.9 COLCHICINE RBPL-C0500 64-86-8 C22H25NO6; 399.44 Colchicine Impurity E RBPL-C0501 7336-33-6 C₂₁H₂₃NO₆; 385.41 Colchicine Impurity A RBPL-C0502 7411-12-3 C₂₁H₂₃NO₆; 385.41
  • 4.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 4 of 16    Colchicine Impurity D (Colchicoside) RBPL-C0503 477-29-2 C27H33NO11; 547.55 CLOMIPRAMINE RBPL-C0700 303-49-1 C19H23ClN2; 314.85 Clomipiramine Impurity G RBPL-C0701 1425793-87-8 C17H16ClN; 269.77 Clomipiramine N-Oxide RBPL-C0705 14171-67-6 C19H23ClN2O; 330.85 CLOZAPINE RBPL-C0800 5786-21-0 C18H19ClN4 326.83 Clozapine Impurity D RBPL-C0801 65514-71-8 C18H21ClN4O; 344.84 Clozapine-N-oxide RBPL-C0802 34233-69-7 C18H19ClN4O; 342.82 CARVEDILOL RBPL-C1000 72956-09-3 C24H26N2O4 406.48 Carvedilol Impurity A (Carvedilol Related Compound A) RBPL-C1001 1076199-79-5 C₃₆H₄₃N₃O₇; 629.74 Carvedilol Impurity C (Carvedilol Related Compound C) RBPL-C1002 72955-94-3 C31H32N2O4 ; 496.6 CETIRIZINE RBPL-C1100 83881-51-0 C21H25ClN2O3; 388.89 Cetirizine -N-oxide RBPL-C1101 1076199-80-8 C21H25ClN2O4; 404.8 Cetirizine Impurity A (Hydroxyzine Related Compound A) RBPL-C1102 303-26-4 C₁₇H₁₉ClN₂; 286.8 CLOTRIMAZOLE RBPL-C1200 23593-75-1 C22H17ClN2 344.84 Clotrimazole Impurity E RBPL-C1201 5162-03-8 C₁₃H₉ClO; 216.66 CYCLOPHOSPHAMIDE RBPL-C1300 50-18-0 C7H15Cl2N2O2P; 261.09 Cyclophosphamide Related Compound A RBPL-C1301 821-48-7 (HCl) 334-22-5 (FB) C₄H₁₀Cl₃N; 178.49 CELECOXIB RBPL-C1400 169590-42-5 C17H14F3N3O2S; 381.37 Celecoxib Impurity A (Celecoxib Related Compound A) RBPL-C1401 170570-01-1 C17H14F3N3O2S; 381.38 CIPROFLOXACIN RBPL-C1500 85721-33-1 C17H18FN3O3; 331.34 Ciprofloxacin Impurity F (Ciprofloxacin 6-Hydroxy Analog) RBPL-C1501 226903-07-7 C17H19N3O4; 329.35 CHLORPROMAZINE RBPL- C1700 50-53-3 C17H19ClN2S; 318.86 Chlorpromazine N-oxide| RBPL-C1702 1672-76-0 C17H19ClN2OS; 334.86 Chlorpromazine Impurity C RBPL-C1705 53-60-1 (HCl) 58-40-2 (FB) C17H21ClN2S;320.88 Chlorpromazine N-Desmethyl RBPL-C1706 CARBAMAZEPINE RBPL-C1800 298-46-4 C15H12N2O; 236.27 Carbamazepine Impurity D (Carbamazepine Related Compound B) RBPL-C1801 256-96-2 C₁₄H₁₁N; 193.24 Carbamazepine Impurity E RBPL-C1802 494-19-9 C₁₄H₁₃N; 195.26 Carbamazepine N-oxide (Carbamazepine Epoxide) RBPL-C1804 36507-30-9 C₁₅H₁₂N₂O₂; 252.27 Carbamazepine Impurity A (Carbamazepine Related Compound A) RBPL-C1805 3564-73-6 C15H14N2O; 238.28 CHLORPHENIRAMINE / CHLORPHENAMINE RBPL-C2300 132-22-9 C16H19ClN2. 274.79 Chlorpheniramine N-Oxide RBPL-C2301 142494-45-9 C16H19ClN2O; 290.79 Chlorpheniramine Impuity B (Chlorpheniramine Related Compound B) RBPL-C2302 1202-34-2 C₁₀H₉N₃; 171.2 Chlorpheniramine Impuity C RBPL-C2303 20619-12-9 22630-25-7(FB) C₁₅H₁₇ClN₂; 260.76 Chlorpheniramine Impuity A RBPL-C2304 1246816-57-8 C16H24ClN3; 293.8 CAFFEINE RBPL-C2500 58-08-2 C8H10N4O2; 194.19 Caffeine Impurity C RBPL-C2501 519-32-4 C₈H₁₀N₄O₂; 194.19 Caffeine Impurity E RBPL-C2502 20041-90-1 C7H12N4O; 168.2 CLOMIPHENE RBPL-C2600 911-45-5 C26H28ClNO; 406.0 Clomiphene N-oxide RBPL-C2601 97642-74-5 C₂₆H₂₈ClNO₂; 421.96 CYPROHEPTADINE RBPL-C2700 Cyproheptadine N-oxide RBPL-C2701 100295-63-4 C₂₁H₂₁NO; 303.41 CHLORAMPHENICOL RBPL-C2900 56-75-7 C11H12Cl2N2O5; 323.13 Chloramphenicol Impurity B RBPL-C2901 555-16-8 C7H5NO3 ; 151.12 Chloramphenicol Impurity RBPL-C2902 2964-48-9 C9H12N2O4; 212.21 CINNARIZINE RBPL-C3700 Cinnarizine N-oxide RBPL-C3702 CYCLOBENZAPRINE RBPL-C4000 303-53-7 C₂₀H₂₁N; 275.39 Cyclobenzaprine N-Oxide RBPL-C4001 6682-26-4 C20H21NO; 291.4
  • 5.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 5 of 16    CHOLECALCIFEROL RBPL-C4100 67-97-0 C27H44O ; 384.65 CLOBETASOL RBPL-C4200 25122-46-7 C25H32ClFO5; 466.97 Clobetasol Impurity J (Clobetasol Related Compound A) RBPL-C4201 1486466-31-2 C25H30ClFO4;448.95 DICLOFENAC RBPL-D0100 15307-86-5 C14H11Cl2NO2 296.15 Diclofenac Impurity A (Diclofenac Related Compound A) (Diclofenac Lactum) (Aceclofenac Impurity I) (Diclofenac Amide) RBPL-D0101 15362-40-0 C₁₄H₉Cl₂NO; 278.13 Diclofenac isopropyl Impurity RBPL-D0102 66370-79-4 C17H17Cl2NO2; 338.24 Diclofenac methyl ester Impurity (Aceclofenac Impurity B) RBPL-D0103 15307-78-5 C15H13Cl2NO2; 310.18 Diclofenac Impurity F RBPL-D0104 560075-65-2 C14H10Cl3NO; 314.59 Diclofenac Impurity D (Diclofenac Related Compound D) RBPL-D0106 127792-45-4 C14H10BrClNNaO2; 362.58 Diclofenac Free Acid (Aceclofenac Impurity A) (Diclofenac Impurity K) RBPL-D0108 15307-86-5 C₁₄H₁₁Cl₂NO₂; 296.15 DOMPERIDONE RBPL-D0200 57808-66-9 C22H24ClN5O2; 425.91 Domperidone Impurity A RBPL-D0201 53786-28-0 C12H14ClN3O; 251.71 Domperidone Impurity B RBPL-D0202 1346598-11-5 C13H14ClN3O2; 279.72 Domperidone Impurity (Droperidol) RBPL-D0203 548-73-2 C22H22FN3O2; 379.43 Domperidone N-oxide (Domperidone Impurity C) RBPL-D0205 118435-03-3 C22H24ClN5O3; 441.9 DESVENLAFAXINE RBPL-D0300 93413-62-8 C16H25NO2; 263.381 Desvenlafaxine-N-oxide RBPL-D0301 NA C16H25NO3; 279.37 DESLORATADINE RBPL-D0500 100643-71-8 C19H19ClN2; 310.82 Desloratadine dehydro impurity RBPL-D0502 117811-20-8 C19H17ClN2; 308.80468 Desloratadine deschloro Impurity RBPL-D0503 38092-95-4 C19H20N2; 276.38 Desloratadine Related Compound F (Desloratadine N-Formyl) RBPL-D0504 117810-61-4 C₂₀H₁₉ClN₂O; 338.83 DIPYRIDAMOLE RBPL-D0600 58-32-2 C24H40N8O4; 504.63 Dipyridamole Impurity A (Dipyridamole Related Compound A) RBPL-D0601 16982-40-4 C₂₅H₄₀N₈O₂; 484.64 Dipyridamole Impurity B (Dipyridamole Related Compound B) RBPL-D0602 16908-47-7 C23H40N8O6; 524.61 Dipyridamole Impurity E (Dipyridamole Related Compound E) RBPL-D0603 2365420-11-5 C24H40N8O4; 504.63 DUTASTERIDE RBPL-D0700 164656-23-9 C27H30F6N2O2; 528.53 Dutasteride Impurity C RBPL-D0701 157307-36-3 C21H31NO3; 345.48 DORZOLAMIDE RBPL-D0800 130693-82-2 C10H16N2O4S3 · HCl; 360.90 Dorzolamide Impurity D (Dorzolamide Related Compound D) RBPL-D0801 164455-27-0 C8H12N2O4S3. HCl; 296.39 36.46 DIPHENHYDRAMINE RBPL-D0900 58-73-1 C17H21NO 255.36 Diphenhydramine Impurity A (Diphenhydramine Related Compound A) RBPL-D0901 17471-10-2(FB) 53499-40-4(Hcl) C16H19NO HCl; 241.34 36.46 DARIFENACIN RBPL-D1000 Free Amine: 133099-04-4 133099-07-7 C₂₈H₃₁BrN₂O₂; 507.46 7-bromoethyl darifenacin RBPL-D1001 NA C10H11BrO; 227.1 Darifenacin N-oxide RBPL-D1002 1391080-40-2 C₂₈H₃₀N₂O₃; 442.55 DONEPEZIL RBPL-D1100 120014-06-4 C24H29NO3, 379.50 Donepezil benzyl bromide (Donepezil Impurity H) RBPL-D1101 844694-85-5 C31H36BrNO3; 550.53 Donepezil dihydro RBPL-D1102 120011-70-3 C₂₄H₃₀ClNO₃; 415.95 Donepezil N-oxide (Donepezil Impurity D) RBPL-D1103 120013-84-5 C₂₄H₂₉NO₄; 395.49 DEXTROMETHORPHAN RBPL-D1600 125-71-3 C18H25NO 271.40 Dextromethorphan N-Oxide RBPL-D1601 1177494-18-6 C18H25NO2; 287.4 DASATINIB RBPL-D1900 302962-49-8 C22H26ClN7O2S; 488.01 Dasatinib N-oxide (Dasatinib Impurity F) RBPL-D1901 910297-52-8 C₂₂H₂₆ClN₇O₃S; 504 DOXEPIN RBPL-D2100 1668-19-5 C19H21NO; 279.383 Doxepin N-Oxide RBPL-D2101 22684-91-9 C₁₉H₂₁NO₂; 295.38 DILTIAZEM RBPL-D2600 42399-41-7 C22H26N2O4S. 414.52 Diltiazem N-oxide (Diltiazem Sulphoxide) RBPL-D2601 142843-04-7 C₂₂H₂₆N₂O₅S; 430.52 Diltiazem Sulphone RBPL-D2602 NA C22H26N2O6S; 446.52 DIGOXIN RBPL-D3000 20830-75-5 C41H64O14; 780.94
  • 6.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 6 of 16    Digoxin Impurity H RBPL-D3001 17575-22-3 C49H76O20; 985.12 DOXYLAMINE RBPL-D3300 Doxylamine N-oxide (Ethanolamine) RBPL-D33 97143-65-2 Hcl (NA) C₁₇H₂₂N₂O₂; 286.37 DIACEREIN RBPL-D3400 Diacerein Impurity B RBPL-D3401 481-72-1 C15H10O5; 270.24 ETORICOXIB RBPL-E0100 202409-33-4 C18H15ClN2O2S; 358.84 Etoricoxib N-Oxide RBPL-E0101 325855-74-1 C18H15ClN2O3S ; 374.85 ERYTHROMYCIN RBPL-E0200 114-07-8 C37H67NO13; 733.93 Erythromycin Impurity H (Erythromycin N-oxide) RBPL-E0201 992-65-4 C₃₇H₆₇NO₁₄; 749.93 Erythromycin Impurity B (3’N-desmethyl erythromycin A) (Clarithromycin Impurity R) RBPL-E0202 992-62-1 C36H65NO13; 719.90 Erythromycin Impurity D (Anhydro Erythromycin) RBPL-E0203 23893-13-2 C₃₇H₆₅NO₁₂; 715.91 Erythromycin Impurity E (Erythromycin A Enol Ether) RBPL-E0204 33396-29-1 C₃₇H₆₅NO₁₂; 715.92 Erythromycin Impurity F (Pseudo Erythromycin A Enol Ether) RBPL-E0205 105822-69-7 C37H65NO12; 715.93 Erythromycin Impurity L (N-desmethyl – N-formoyl erythromycin A) RBPL-E0206 127955-44-6 C37H65NO14; 747.91 Erythromycin 9-Oxime Impurity (Clarithromycin Impurity J) (Azithromycin Impurity S) (Roxithromycin Impurity C) RBPL-E0207 13127-18-9 C₃₇H₆₈N₂O₁₃; 748.94 EMTRICITABINE RBPL-E0300 143491-57-0 C8H10FN3O3S; 247.25 Emtricitabine Sulfoxide (Emtricitabine Impurity-G) RBPL-E0301 152128-77-3 C₈H₁₀FN₃O₄S; 263.25 ENALAPRIL RBPL-E0400 75847-73-3 C20H28N2O5 · C4H4O4; 492.52 Enalapril DKP Impurity D RBPL-E0402 115729-52-7 C₂₀H₂₆N₂O₄; 358.43 ERLOTINIB RBPL-E0500 183321-74-6 C22H23N3O4, 393.44 Erlotinib Hcl N-Oxide RBPL-E0501 NA C22H23N3O5 ; 409.44 ENROFLOXACIN RBPL-E0600 93106-60-6 C19H22FN3O3; 359.39 Enrofloxacin N-oxide RBPL-E0603 185460-67-7 C19H22FN3O4; 375.39 Enrofloxacin Methyl Ester RBPL-E0604 ERGOCRYPTINE RBPL-E1500 FAMOTIDINE RBPL-F0100 76824-35-6 C8H15N7O2S3; 337.45 Famotidine Impurity B (Famotidine Related Compound B) RBPL-F0101 109467-08-5 (Dimaleate) ; 89268-62-2 C16H23N11O2S5 ; 561.75 Famotidine Impurity E (Famotidine Related Compound E) RBPL-F0102 129083-44-9 C₁₀H₁₄N₈S₄; 374.53 Famotidine Impurity D (Famotidine Related Compound D) RBPL-F0103 76824-16-3 C8H13N5OS2 ; 259.35 FOSINOPRIL RBPL-F0200 98048-97-6 C30H45NO7P · Na; 585.64 Fosinopril Impurity A (Fosinopril Related Compound A) (Fosinoprilat) RBPL-F0201 95399-71-6 C₂₃H₃₄NO₅P; 435.49 FENOFIBRATE RBPL-F0400 49562-28-9 C20H21ClO4; 360.83 Fenofibrate Impurity A (Fenofibrate Related Compound A) RBPL-F0401 42019-78-3 C13H9ClO2; 232.67 Fenofibrate Impurity B (Fenofibrate Related Compound B) RBPL-F0402 42017-89-0 C17H15ClO4; 318.75 Fenofibrate Impurity G (Fenofibrate Related Compound C) RBPL-F0403 217636-48-1 C24H27ClO6; 446.92 Fenofibrate Impurity C RBPL-F0404 217636-47-0 C17H15ClO3; 302.75 Fenofibrate Impurity F RBPL-F0405 154356-96-4 C16H15ClO2; 274.74 FINASTERIDE RBPL-F0500 98319-26-7 C23H36N2O2; 372.54 Finasteride Impurity A RBPL-F0501 98319-24-5 C₂₃H₃₈N₂O₂ ; 374.56 Finasteride Impurity B RBPL-F0502 103335-41-7 C₂₀H₂₉NO₃; 331.45 FLUTICASONE RBPL-F0600 80474-14-2 C25H31F3O5S; 500.57 Fluticasone Related Compound A RBPL-F0601 948566-12-9 C₂₄H₃₀F₂O₆S; 484.55 Fluticasone Related Compound C RBPL-F0602 80474-24-4 C₂₄H₂₉F₃O₅S; 486.54 Fluticasone Related Compound D RBPL-F0603 73205-13-7 C₂₅H₃₂F₂O₅S; 482.58 FEXOFENADINE RBPL-F0700 83799-24-0 C32H39NO4; 501.667 Fexofenadine Impurity A (Fexofenadine Related Compound A) RBPL-F0701 76811-98-8 C₃₂H₃₇NO₄; 499.64 Fexofenadine Impurity C RBPL-F0702 185066-37-9 C31H39NO2; 457.64
  • 7.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 7 of 16    Fexofenadine N-Oxide RBPL-F0703 1422515-52-3 C32H39NO5; 517.67 FUROSEMIDE RBPL-F1100 54-31-9 C12H11ClN2O5S; 330.74 Furosemide Impurity C (Furosemide Related Compound B) RBPL-F1102 3086-91-7 C7H7ClN2O4S; 250.66 FOLIC ACID RBPL-F1300 59-30-3 C19H19N7O6; 441.40 Folic acid Impurity A RBPL-F1302 4271-30-1 C12H14N2O5; 266.25 Folic acid Impurity D RBPL-F1303 119-24-4 C₁₄H₁₂N₆O₃; 312.28 FLAVOXATE RBPL-F1600 15301-69-6 C24H25NO4, 391.46. Flavoxate N-Oxide (HCl) RBPL-F1602 407.52 FENSPIRIDE RBPL-F1700 5053-06-5 C15H16D5ClN2O2, 301.82. Fenspiride N-Oxide RBPL-F1701 210690-26-9 C15H20N2O3, 276.33 FELODIPINE RBPL-F1900 72509-76-3 C18H19Cl2NO4; 383.069 Felodipine Related Compound A RBPL-F1901 96382-71-7 C18H17Cl2NO4 382.24 FENPIVERINIUM RBPL-F2000 Fenpiverinium Bromide Impurity A RBPL-F2001 77-01-0 C21H26N2O; 322.45 FLUOXETINE RBPL-F2100 Fluoxetine Dimethyl Amine RBPL-F2101 885101-12-2 C18H21ClF3NO;359.81 GALANTAMINE RBPL-G0100 357-70-0 C17H21NO3, 287.35 Galantamine Impurity B (Epi Galantamine) RBPL-G0101 1668-85-5 C17H21NO3; 287.35 Galantamine Impurity D (Anhydro Galantamine) RBPL-G0102 664995-65-7 C17H19NO2; 269.34 O-desmethyl Galantamine RBPL-G0103 60755-80-8 C₁₆H₁₉NO₃; 273.33 Galantamine N-Oxide RBPL-G0104 134332-50-6 C₁₇H₂₁NO₄; 303.35 Galantamine Impurity E RBPL-G0105 41303-74-6 C16H1z NO3 ; 273.33 Galantamine Impurity C RBPL-G0106 21133-52-8 C17 H23 NO3 ; 289.38 GABAPENTIN RBPL-G0200 60142-96-3 C9H17NO2 171.24 Gabapentin Impurity A (Gabapentin Related Compound A) RBPL-G0201 64744-50-9 C₉H₁₅NO; 153.22 Gabapentin Impurity B (Gabapentin Related Compound B) RBPL-G0202 133481-09-1 C₉H₁₃NO₂; 167.21 Gabapentin Impurity D (Gabapentin Related Compound D) RBPL-G0203 1076198-17-8 C₁₈H₂₉NO₃; 307.43 Gabapentin Impurity E (Gabapentin Related Compound E) RBPL-G0204 67950-95-2 C9H14O4; 186.21 GLIMEPIRIDE RBPL-G0300 93479-97-1 C24H34N4O5S; 490.62 Glimepiride Impurity B (Glimepiride Related Compound B) RBPL-G0301 119018-29-0 C₁₆H₂₁N₃O₄S; 351.42 Glimepiride Impurity A (Glimepiride Related Compound A) RBPL-G0302 684286-46-2 C₂₄H₃₄N₄O₅S; 490.62 Glimepiride Impurity C (Glimepiride Related Compound C) RBPL-G0303 119018-30-3 C₁₈H₂₃N₃O₆S; 409.46 Glimepiride Impurity D (Glimepiride Related Compound D) RBPL-G0304 791104-62-6 C₂₄H₃₄N₄O₅S; 490.62 GLICLAZIDE RBPL-G0400 21187-98-4 C15H21N3O3S; 323.41 Gliclazide Impurity B RBPL-G0401 54786-86-6 C7H12N2O; 140.18 Gliclazide Impurity F RBPL-G0402 1076198-18-9 C15H21N3O3S; 323.41 GUAIFENESIN RBPL-G0500 93-14-1 C10H14O4; 198.22 Guaifenesin Impurity B (Guaifenesin Related Compound B) RBPL-G0501 14007-09-1 C₁₀H₁₄O₄; 198.22 GEFITINIB RBPL-G0600 184475-35-2 C22H24ClFN4O3; 446.91 Gefitinib Morpholine N-oxide RBPL-G0601 847949-51-3 C22H24ClFN4O4 ; 462.91 GLIBENCLAMIDE RBPL-G0900 10238-21-8 C23H28ClN3O5S; 494.004 Glibenclamide Impurity A RBPL-G0901 16673-34-0 C16H17ClN2O4S; 368.84 Glibenclamide Impurity B RBPL-G0902 21165-77-5 C18H19ClN2O6S; 426.87 HALOPERIDOL RBPL-H0300 52-86-8 C21H23ClFNO2 375.86 Haloperidol N-Oxide (Haloperidol Impurity–H) RBPL-H0301 148406-51-3 C₂₁H₂₃ClFNO₃; 391.86 HYDROCORTISONE ACETATE RBPL-H0500 50-03-3 C23H32O6; 404.50 HYDROXYCHLOROQUINE RBPL-H0600 118-42-3 C18H26ClN3O; 335.872 Hydroxychloroquine N-oxide RBPL-H0601 IMATINIB RBPL-I0100 152459-95-5 C29H31N7O; 493.60 Imatinib Impurity E (Imatinib Dimer) RBPL-I0101 1365802-18-1 C₅₂H₄₈N₁₂O₂; 873.02 Imatinib (Pyridine) N-oxide RBPL-I0102 571186-92-0 C29H31N7O2; 509.60 Imatinib piperazine N-Oxide RBPL-I0103 571186-91-9 C29H31N7O2; 509.62 Imatinib (Piperidine)-N,N-dioxide RBPL-I0104 571186-93-1 C₂₉H₃₁N₇O₃ ; 525.60 IBUPROFEN RBPL-I0200 15687-27-1 C13H17O2; 205.27
  • 8.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 8 of 16    Ibuprofen Impurity L RBPL-I0201 53949-53-4 C13H18O3; 222.28 Ibuprofen Impurity E (Ibuprofen Related Compound C) RBPL-I0202 38861-78-8 C12H16O; 176.25 Ibuprofen Impurity A RBPL-I0203 66622-47-7 C₁₃H₁₈O₂; 206.28 Ibuprofen Impurity N RBPL-I0204 3585-52-2 C₁₁H₁₄O₂; 178.23 Ibuprofen Impurity B RBPL-I0205 3585-49-7 C13H18O2; 206.28 Ibuprofen Impurity J (Ibuprofen Related Compound J) RBPL-I0206 65813-55-0 C₁₃H₁₆O₃; 220.26 Ibuprofen impurity F RBPL-I0207 65322-85-2 C13H18O2; 206.28 ITRACONAZOLE RBPL-I0300 84625-61-6 C35H38Cl2N8O4; 705.63 Itraconazole Impurity C RBPL-I0301 74855-91-7 C34H36Cl2N8O4; 691.61 Itraconazole N,N-dioxide RBPL-I0302 NA C₃₅H₃₈Cl₂N₈O6; 737.63 Itraconazole N-oxide RBPL-I0302 NA C35H38Cl2N8O; 721.65 IRBESARTAN RBPL-I0500 Irbesartan Related Compound A RBPL-I0501 748812-53-5 C25H30N6O2; 446.54 INDORAMIN RBPL-I1000 Indoramin Impurity C RBPL-I1001 33953-37-6 C₁₂H₁₆N₂O;204.27 Indoramin Hcl Impurity A RBPL-I1002 3389-21-7 INDOMETACIN RBPL-I1100 53-86-1 C19H16ClNO4 357.79 KETORALAC RBPL-K0100 74103-06-3 C15H13NO3, 255.27 Ketoralac Impurity D RBPL-K0101 1391053-45-4 C16H14NNaO4 ;307.0821; 285 Ketorolac Impurity B (Ketorolac Related Compound C) RBPL-K0102 113502-52-6 C₁₄H₁₁NO₂; 225.24 Ketorolac Impurity E (Ketorolac Related Compound A) RBPL-K0103 167105-80-8 C19H22N2O5; 358.39 Ketorolac Impurity A (Ketorolac Related Compound B) RBPL-K0104 154476-25-2 C₁₄H₁₃NO₂; 227.26 Ketorolac Impurity I (Ketorolac Related Compound D) RBPL-K0105 113502-55-9 C₁₄H₁₃NO; 211.26 KETOCONAZOLE RBPL-K0200 65277-42-1 C26H28Cl2N4O4; 531.43 Ketoconazole-N-Oxide RBPL- K0201 254912-65-7 C26H28Cl2N4O5; 547.43 Ketoconazole Impurity D RBPL- K0202 67914-61-8 C24H26Cl2N4O3; 489.4 KETOPROFEN RBPL-K0300 Ketoprofen Methyl Ester RBPL-K0301 LEFLUNOMIDE RBPL-L0200 75706-12-6 C12H9F3N2O2; 270.21 Leflunomide Impurity E RBPL-L0201 208401-20-1 C₁₂H₉F₃N₂O₂; 270.21 LAMOTRIGINE RBPL-L0300 84057-84-1 C9H7Cl2N5 256.09 Lamotrigine Impurity F (Lamotrigine Related Compound D) RBPL-L0301 252186-79-1 C16H9Cl4N5O; 429.09 Lamotrigine Impurity G RBPL-L0302 38943-76-9 C9H5Cl2N3O2; 258.06 Lamotrigine N-Oxide RBPL-L0303 136565-76-9 C₉H₇Cl₂N₅O; 272.09 LANSOPRAZOLE RBPL-L0400 103577-45-3 C16H14F3N3O2S; 369.36 Lansoprazole sulphone (Lansoprazole Impurity-B) (Lansoprazole Related Compound A) RBPL-L0401 131926-99-3 C₁₆H₁₄F₃N₃O₄S; 385.36 Lansoprazole sulphone (Lansoprazole N-oxide) RBPL-L0402 953787-54-7 C16H14F3N3O4S; 401.36 Lansoprazole Impurity C (Lansoprazole Sulphide) (Lansoprazole Related Compound B) RBPL-L0403 103577-40-8 C16H14F3N3OS; 353.36 Lansoprazole chloro RBPL-L0404 127337-60-4 C9H10Cl2F3NO; 276.08 Lansoprazole Impurity E (Rabeprazole Related Compound C) (Rabeprazole Impurity F) RBPL-L0405 583-39-1 C8H6F2N2OS; 216.21 S-Lansoprazole RBPL-L0406 138530-95-7 C16H14F3N3O2S; 369.36 LEVOFLOXACIN RBPL-L0500 100986-85-4 C18H20FN3O4; 361.37 Levofloxacin Hemihydrate RBPL-L0500 138199-71-0 C18H20FN3O4.1/2.H2O; 370.38 Levofloxacin Impurity F (Levofloxacin Related Compound B) RBPL-L0501 100986-89-8 C₁₃H₉F₂NO₄; 281.21 Levofloxacin-N-oxide (Impurity C) RBPL-L0502 117678-38-3 C18H20FN3O5; 377.36 Levofloxacin Impurity B (Levofloxacin Related Compound A) (Levofloxacin N-desmethyl) RBPL-L0503 117707-40-1 C17H18FN3O4; 347.34 Levofloxacin Impurity A (Levofloxacin D-Isomer) RBPL-L0504 100986-86-5 C18H20FN3O4 ; 361.37 Levofloxacin Impurity G (Levofloxacin Related Compound E) RBPL-L0505 1346603-62-0 C16H18FN3O4; 371.79 LOPERAMIDE RBPL-L0600 53179-11-6 C29H33ClN2O2, 477.04 Loperamide Impurity B RBPL-L0601 NA C47H53ClN3O3; 743.4
  • 9.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 9 of 16    Loperamide Impurity F (Loperamide Trans-N-Oxide) (Loperamide Related Compound F) RBPL-L0602 106900-12-3 C29H33ClN2O3; 493.05 Loperamide Impurity G (Cis-N-Oxide) RBPL-L0603 109572-89-6 C29H33ClN2O3; 493.04 Loperamide Impurity A RBPL-L0604 1391052-94-0 C35H37ClN2O2; 553.143 Loperamide Impurity C RBPL-L0605 39512-49-7 C₁₁H₁₄ClNO; 211.69 Loperamide Impurity H (Anhydro Loperamide) RBPL-L0606 61299-42-1 C₂₉H₃₁ClN₂O; 459.02 LORATADINE RBPL-L0700 79794-75-5 C22H23N2O2Cl; 382.88 Loratadine Impurity D (Loratadine Related Compound A) RBPL-L0702 100643-71-8 C19H19ClN2; 310.82 Loratadine Impurity B (Loratadine Related Compound C) RBPL-L0703 31251-41-9 C₁₄H₁₀ClNO; 243.69 LAMIVUDINE RBPL-L0900 134678-17-4 C8H11N3O3S; 229.26 Lamivudine R-Sulphoxide RBPL-L0903 160552-54-5 C₈H₁₁N₃O₄S; 245.26 LEVOCETRIZINE RBPL-L1000 Levocetrizine Amide RBPL-L1001 909779-33-5 C21H26ClN3O2; 387.90 Levocetrizine CBHP (Chlorobenzyldryl Piperazine) RBPL-L1002 300543-56-0 C₁₇H₁₉ClN₂; 286.8 LEVETIRACETAM RBPL-L1100 102767-28-2 C8H14N2O2; 170.21 Levetiracetam Impurity G (Levetiracetam Related Compound B) RBPL-L1101 7682-20-4 C₄H₁₁ClN₂O; 138.6 LIDOCAINE RBPL-L1500 137-58-6 C14H22N2O; 234.34 Lidocaine N-Oxide RBPL-L1503 2903-45-9 C14H22N2O2; 250.34 LINEZOLID RBPL-L1900 165800-03-3 C16H20FN3O4; 337.35 Linezolid N-oxide RBPL-L1901 189038-36-6 C16H20FN3O5; 353.35 Linezolid Related Compound A RBPL-L1902 168828-84-0 C14H16FN5O3; 321.31 LUMEFANTRINE RBPL-L2000 82186-77-4 C30H32Cl3NO; 528.94 Lumefantrine N-oxide RBPL-L2001 NA C30H32NO2Cl3; 543.15 METOPROLOL RBPL-M0200 37350-58-6 C15H25NO; 267.36 Metoprolol Epoxide RBPL-M0201 56718-70-8 C₁₂H₁₆O₃; 208.25 Metoprolol Impurity H (Betaxolol Impurity B) RBPL-M0202 62572-94-5 C₁₄H₂₃NO₃; 253.34 Metoprolol Impurity B RBPL-M0203 56718-71-9 C₉H₁₂O₂ ; 152.19 Metoprolol Impurity G RBPL-M0204 501-94-0 C₈H₁₀O₂ ; 138.16 Metoprolol Impurity M RBPL-M0205 73313-36-7 C₉H₂₄Cl₂N₂O ; 247.21 Metoprolol Impurity N RBPL-M0206 6452-57-9 (FB) C₆H₁₅NO₂; 133.19 Metoprolol Impurity O (Metoprolol Related Compound D) RBPL-M0207 154784-36-8 1486464-40-7 (Hcl) C₂₇H₄₁NO₆; 475.6 Metoprolol Impurity C (Metoprolol Related Compound C) RBPL-M0208 29122-74-5 C₁₃H₁₉NO₃; 237.29; (C17H23NO7 ; 353.15) maleate Metoprolol Impurity D RBPL-M0209 62572-90-1 C12H18O4; 226.268 Metoprolol Impurity A (Metoprolol Related Compound A) RBPL-M0210 109632-08-8 C₁₄H₂₃NO₃, 253.34 Succinic acid RBPL-M0211 110-15-6 C4H6O4; 118.09 METOCLOPRAMIDE RBPL-M0300 364-62-5 C14H22ClN3O2; 299.8 Metoclopramide Impurity H RBPL-M0301 50-86-2 C9H9NO4; 195.17 Metoclopramide N-oxide (Metoclopramide Impurtiy G) RBPL-M0303 171367-22-9 C₁₄H₂₂ClN₃O₃; 315.8 Metoclopramide Impurity A (Metoclopramide Related Compound A) RBPL-M0304 5608-13-9 C16H24ClN3O3; 341.83 Metoclopramide Impurity E RBPL-M0305 100-36-7 C6H16N2; 116.21 MEFENAMIC ACID RBPL-M0400 61-68-7 C15H15NO2; 241.29 Mefenamic Acid Impurity C RBPL-M0401 118-91-2 C₇H₅ClO₂;156.57 Mefenamic Acid Impurity D RBPL-M0402 65-85-0 C₇H₆O₂; 122.12 Mefenamic Acid Impurity A RBPL-M0403 87-59-2 C8H11N; 121.18 MYCOPHENOLATE RBPL-M0500 24280-93-1 C17H20O6; 320.34 Mycophenolate Impurity F (Mycophenolic Acid) RBPL-M0501 24280-93-1 C₁₇H₂₀O₆; 320.34 Mycophenolate Mofetil N-Oxide (Mycophenolate Impurity G) RBPL-M0502 224052-51-1 C₂₃H₃₁NO₈; 449.49 MONTELUKAST RBPL-M0600 158966-92-8 C35H36ClNO3S. 586.18 Montelukast Dicyclo Hexyl Amine RBPL-M0600 577953-88-9 C47H59ClN2O3S; 767.5 Montelukast Sulfoxide (Montelukast Impurity C) (Montelukast Related Compound A) RBPL-M0601 909849-96-3 C₃₅H₃₆ClNO₄S 602.18
  • 10.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 10 of 16    Montelukast Sulphone RBPL-M0602 1266620-74-9 C₃₅H₃₆ClNO₅S618.18 Montelukast Ketone RBPL-M0603 1258428-71-5 C29H26ClNO2 ; 455.98 Montelukast methylstyrene (Montelukast Impurity-B) (Montelukast Related Compound F) RBPL-M0604 918972-54-0 C35H34ClNO2S ; 568.17 MOXIFLOXACIN RBPL-M0700 354812-41-2 C21H24FN3O4; 401.43 Moxifloxacin Impurity A (Moxifloxacin Related Compound A) RBPL-M0701 151213-15-9 C20H21F2N3O3; 389.40 MODAFINIL RBPL-M0800 68693-11-8 C15H15NO2S; 273.35 Modafinil Sulphone RBPL-M0801 Modafinil Impurity B (Modafinil Related Compound B) RBPL-M0802 118779-53-6 C15H15NO3S; 28; .35 MELOXICAM RBPL-M0900 71125-38-7 C14H13N3O4S2; 351.40 Meloxicam Impurity B (Meloxicam Related Compound B) RBPL-M0901 7305-71-7 C4H6N2S ; 114.17 MEMANTINE RBPL-M1000 19982-08-2 C12H21N; 79.30 Memantine N-oxide RBPL-M1006 1262583-10-7 C₁₂H₁₉NO; 193.29 METFORMIN RBPL-M1200 657-24-9 C4H11N5; 129.16 Metformin Impurity A (Metformin Related Compound A) RBPL-M1201 461-58-5 C₂H₄N₄; 84.08 Metformin Impurity C (Metformin Related Compound C) RBPL-M1202 1985-46-2 C₅H₁₀N₆; 154.17 Metformin Impurity D RBPL-M1203 108-78-1 C₃H₆N₆; 126.12 MIRTAZAPINE RBPL-M1300 61337-67-5 C17H19N3; 265.35 Mirtazapine N-oxide RBPL-M1301 155172-12-6 C17H19N3O; 281.35 MINOXIDIL RBPL-M1800 38304-91-5 C9H15N5O; 209.253 Minoxidil Impurity E (Deoxy Minoxidil) RBPL-M1802 24867-26-3 C9H15N5;193.25 METHYL PARABEN RBPL-M2300 99-76-3 HOC6H4CO2CH3; 152.15 MBTH Hydrochloride RBPL-M2500 4338-98-1 C₈H₉N₃S • HCl; 215.7 3-methyl-2-benzothiazolinonehydrazone Hydrochloride (MBTH) RBPL-M2501 4338-98-1 C₈H₉N₃S • HCl; 215.7 METHYLCOBALAMINE RBPL-M2600 13422-55-4 C63H91CoN13O14P, 1344.38 NIMSULIDE RBPL-N0100 51803-78-2 C13H12N2O5S; 308.31 Nimsulide Impurity D RBPL-N0101 5422-92-4 C12H10N2O3; 230.22 NORADRENALIN RBPL-N0200 51-41-2 C8H11NO3; 169.180 Noradrenalin Impurity E RBPL-N0201 99-40-1 C8H7ClO3; 186.59 Noradrenalin Impurity F RBPL-N0202 20455-68-9 C14H16ClN; 233.74 NAPROXEN RBPL-N0300 22204-53-1 C14H14O3; 230.26 Naproxen Impurity B RBPL-N0301 89617-86-7 C₁₄H₁₃ClO₃; 264.7 Naproxen Impurity D RBPL-N0302 116883-62-6 C₁₄H₁₃IO₃; 356.16 Naproxen Impurity K RBPL-N0303 77301-42-9 C₁₃H₁₄O₂; 202.25 Naproxen Impurity L (Naproxen Related Compound L) RBPL-N0304 3900-45-6 C₁₃H₁₂O₂; 200.23 Naproxen Impurity N RBPL-N0305 5111-65-9 C₁₁H₉BrO; 237.09 Racemic Naproxen RBPL-N0306 23981-80-8 C₁₄H₁₄O₃; 230.26 Naproxen Impurity O (Naproxen Related Compound A) RBPL-N0307 2471-70-7 C₁₂H₁₀O₃; 202.21 Naproxen Methyl Ester RBPL-N0308 Naproxen Ethyl Ester RBPL-N0309 Naproxen Isopropyl Ester RBPL-N0310 NIZATIDINE RBPL-N0400 76963-41-2 C12H21N5O2S2 331.45 Nizatidine Impurity H RBPL-N0401 27366-72-9 C₄H₁₁ClN₂S; 154.66 NEBIVOLOL RBPL-N0500 99200-09-6 C22H25F2NO4; 405.44 Nebivolol Impurity A RBPL-N0501 118457-16-2 C22H25F2NO4; 405.45 Nebivolol Impurity B (Nebivolo Related Compound B) RBPL-N0502 119365-25-2 C22H25F2NO4; 405.45 NIACINAMIDE RBPL-N0700 98-92-0 C6H6N2O; 122.12 Niacinamide N-oxide RBPL-N0701 1986-81-8 C6H6N2O2;138.13 Nicotinamide Impurity D (Nicotine impurity C) (Isonicotinamide) RBPL-N0702 1453-82-3 C₆H₆N₂O; 122.12 NIFEDIPINE RBPL-N0800 21829-25-4 C₁₇H₁₈N₂O₆; 346.33 Nifedipine Impurity B RBPL-N0801 50428-14-3 C17H16N2O5; 328.32
  • 11.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 11 of 16    NILOTINIB RBPL-N1100 641571-10-0 C28H22F3N7O; 529.5245 Nilotinib Impurity C RBPL-N1101 641571-15-5 C28H22F3N7O; 529.53 NALIDIXIC ACID RBPL-N1200 Nalidixic Acid Impurity C RBPL-N1201 87-13-8 C10H16O5; 216.23 NIMODIPINE RBPL-N1300 Nimodipine Impurity A RBPL-N1301 OLANZAPINE RBPL-O0100 132539-06-1 C17H20N4S, 312.43 Olanzapine Impurity D (Olanzapine Related Compound C) (Olanzapine N-oxide) RBPL-O0101 174794-02-6 C17H20N4OS; 328.43 Olanzapine Impurity A (Olanzapine Related Compound A) RBPL-O0102 138564-59-7 C12H9N3O2S; 259.28 Olanzapine Impurity B (Olanzapine Related Compound B) RBPL-O0103 221176-49-4 C12H10N2OS; 230.29 N-Desmethyl Olanzapine RBPL-O0105 161696-76-0 C₁₆H₁₈N₄S; 298.41 OMEPRAZOLE RBPL-O0200 73590-58-6 (FB) C17H19N3O3S; 345.42 Omeprazole Impurity A (Omeprazole Related Compound B) RBPL-O0201 37052-78-1 C8H8N2OS; 180.23 Omeprazole Impurity C (Omeprazole Sulphide) RBPL-O0202 73590-85-9 C17H19N3O2S; 329.42 Omeprazole Impurity F&G RBPL-O0203 125656-82-8 + 125656-83-9 C16H13N3O2S; 311.4 Omeprazole Impurity I (Omeprazole Sulfone N-Oxide) RBPL-O0205 158812-85-2 C17H19N3O5S; 377.41 4-Hydroxy omeprazole sulphide RBPL-O0206 103876-98-8 C16H17N3O2S; 315.39 Omeprazole Related Compound A (Omeprazole Impurity D) (Omeprazole Sulphone) RBPL-O0207 88546-55-8 C₁₇H₁₉N₃O₄S ; 361.42 Omeprazole Impurity E (Omeprazole N-oxide) (Omeprazole Related Compound E) RBPL-O0208 176219-04-8 C₁₇H₁₉N₃O₄S ; 361.42 Omeprazole Impurity B (Esomeprazole Impurity B) RBPL-O0209 110374-16-8 C16H17N3O2S ; 315.39 Omeprazole Impurity H RBPL-O0210 863029-89-4 C₁₆H₁₆ClN₃O₂S; 349.84 OFLOXACIN RBPL-O0300 82419-36-1 C18H20FN3O4; 361.37 Ofloxacin Impurity E (Ofloxacin Related Compound A) RBPL-O0301 82419-52-1 C₁₇H₁₈FN₃O₄ ; 347.34 Ofloxacin N-oxide RBPL-O0302 104721-52-0 C₂₀H₂₄FN₃O₇; 437.42 ONDANSETRON RBPL-O0400 99614-02-5 C18H19N3O; 293.36 Ondansetron Impurity D (Ondansetron Related Compound D) RBPL-O0401 99614-64-9 C₁₄H₁₃NO; 211.26 Ondansetron Impurity B RBPL-O0407 1076198-52-1 C₃₇H₃₈N₆O₂; 598.74 OXYBUTYNIN RBPL-O0500 5633-20-5 C22H31NO3, 357.49 Oxybutynin Impurity D (Oxybutynin Related Compound A) RBPL-O0501 4335-77-7 C14H18O3; 234.29 Phenylcyclohexylglycolic Acid Propargyl Ester RBPL-O0502 81039-74-9 C17H20O3; 272.34 OLMESARTAN RBPL-O0700 144689-63-4 C29H30N6O6; 558.59 Olmesartan Impurity A RBPL-O0701 144689-24-7 C₂₄H₂₆N₆O₃; 446.5 Olmesartan Impurity B (Olmesartan Related Compound A) RBPL-O0702 849206-43-5 C₂₄H₂₄N₆O₂; 428.49 OSIMERTINIB RBPL-O0800 1421373-65-0 C₂₈H₃₃N₇O₂; 499.61 Osimertinib N-Oxide RBPL-O0801 1975982-94-5 C₂₈H₃₃N₇O₃ ; 515.61 PIOGLITAZONE RBPL-P0100 112529-15-4 C19H20N2O3S·HCl; 392.90 Hydroxy Pioglitazone RBPL-P0102 146062-44-4 C₁₉H₂₀N₂O₄S; 372.44 PARACETAMOL / ACETAMINOPHEN RBPL-P0200 103-90-2 CH3CONHC6H4OH; 151.16 Paracetamol Impurity J (Acetaminophen Related Compound J) RBPL-P0201 539-03-7 C8H8ClNO; 169.61 Paracetamol Impurity F (Paracetamol Related Compound F) (4-Nitrophenol) RBPL-P0202 100-02-7 C6H5NO3; 139.11 Paracetamol Impurity K (Related Compound K) (4-Aminophenol) RBPL-P0203 51-78-5 (HCl) 123-30-8 (FB) C6H7NO.HCl; 109.13; 145.59 Paracetamol Impurity A (Acetaminophen Related Compound C) RBPL-P0204 614-80-2 C₈H₉NO₂; 151.16 Paracetamol Impurity B (Acetaminophen Related Compound B) RBPL-P0205 1693-37-4 C9H11NO2;165.19 PROPAFENONE RBPL-P0300 54063-53-5 C21H27NO3; 341.44 Propafenone Impurity A RBPL-P0301 3516-95-8 C15H14O2; 226.27 Propafenone Impurity C RBPL-P0302 22525-95-7 C18H18O3; 282.33 Propafenone Impurity E RBPL-P0304 165279-79-8 C18H19ClO3; 318.79
  • 12.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 12 of 16    Propafenone Impurity F RBPL-P0305 1329643-40-4 C33H32O5; 508.6 Propafenone Impurity H RBPL-P0306 27439-12-9 C15H12O2; 224.2 PROMETHAZINE RBPL-P0400 60-87-7 C17H20N2S; 284.42 Promethazine Impurity D (Promethazine Sulphoxide) RBPL-P0401 7640-51-9 C17H20N2OS; 300.42 Promethazine Impurity A RBPL-P0402 92-84-2 C12H9NS; 199.27 Promethazine Impurity B (Promethazine Related Compound B) (Iso Promethazine) RBPL-P0403 5568-90-1 C₁₇H₂₁ClN₂S; 320.88 Promethazine Impurity C (N-Demethyl Promethazine) RBPL-P0404 60113-77-1 C₁₆H₁₉ClN₂S; 306.85 PACLITAXEL RBPL-P0500 33069-62-4 C47H51NO14; 853.91 Paclitaxel Related Compound B (Paclitaxel Impurituy H) RBPL-P0501 78454-17-8 C45H49NO13; 811.87 PROPRANOLOL RBPL-P0600 525-66-6 C16H21NO2; 259.34 Propranolol Impurity A (Propranolol Related Compound A) RBPL-P0601 36112-95-5 C₁₃H₁₄O₃; 218.25 Propranolol Impurity C RBPL-P0602 17216-10-3 C₂₃H₂₀O₃; 344.4 PALONOSETRON RBPL-P0700 135729-62-3 Free cmpd: 135729-61-2 C₁₉H₂₄N₂O • (HCl); 296.41 Dehydropalonosetron RBPL-P0701 NA C19H23ClN2O; 330.85 PANTOPRAZOLE RBPL-P0800 102625-70-7 C16H15F2N3O4S, 383.37 Pantoprazole Impurity A (Pantoprazole Related Compound A) (Pantoprazole Sulphone) RBPL-P0801 127780-16-9 C₁₆H₁₅F₂N₃O₅S399.37 Pantoprazole Impurity B (Pantoprazole Related Compound B) (Pantoprazole Sulfide) RBPL-P0802 102625-64-9 C₁₆H₁₅F₂N₃O₃S367.37 Pantoprazole Impurity C (Pantoprazole Related Compound C) RBPL-P0803 97963-62-7 C₈H₆F₂N₂OS; 216.21 Pantoprazole Sulfone (Pantoprazole N-oxide) RBPL-P0804 953787-55-8 C₁₆H₁₅F₂N₃O₆S415.37 PAROXETINE RBPL-P0900 61869-08-7 C19H20FNO3; 329.37 Paroxetine Impurity I RBPL-P0901 220548-73-2 C₁₂H₁₇ClFNO; 245.72 PYRIDOXINE RBPL-P1100 65-23-6 C8H11NO3; 169.18 Pyridoxine Impurity B Hcl RBPL-P1101 148-51-6 Hcl C₈H₁₂ClNO₂; 189.64 Pyridoxine Impurity A Hcl RBPL-P1102 1006-21-9 C8H9NO2 ; HCl; 151.17 ; 36.46 PARBENDAZOLE RBPL-P1200 14255-87-9 C13H17N3O2; 247.29 PREGABALIN RBPL-P1300 148553-50-8 C8H17NO2; 159.23 Pregabalin Impurity PG-3 (Pregabalin Impurity 4) RBPL-P1301 75143-89-4 C₉H₁₆O₄; 188.22 Pregabalin Impurity PG-2 (Pregabalin Impurity 9) RBPL-P1302 916982-10-0 C₉H₁₅NO₂; 169.22 Pregabalin Related Compound C (Pregabalin Lactam) RBPL-P1303 61312-87-6 C₈H₁₅NO;141.21 Pregabalin Inhouse Impurity (Pregabalin Impurity 5) RBPL-P1304 181289-15-6 C₉H₁₇NO₃; 187.24 Pregabalin Impurity A (Pregabalin Related Compound C) ((S)-Pregabalin Lactam) RBPL-P1305 181289-23-6 C₈H₁₅NO; 141.21 Pregabalin Impurity B (Pregabalin Related Compound A) ((R)-Pregabalin) (Pregabalin enantiomer) RBPL-P1307 148553-51-9 C₈H₁₇NO₂; 159.23 Pregabalin Impurity C RBPL-P1308 90-64-2 C₈H₈O₃; 152.15 Pregabalin Impurity D RBPL-P1309 4118-51-8 C₁₁H₁₄O₃; 194.23 PHENYTOIN RBPL-P1400 57-41-0 C15H12N2O2; 252.27 Phenytoin Impurity C (Phenytoin Related Compound A) RBPL-P1403 3060-50-2 C₁₄H₁₃NO₂; 227.26 PALIPERIDONE RBPL-P1500 144598-75-4 C23H27FN4O3; 426.48 Palliperidone N-oxide RBPL-P1501 761460-08-6 C₂₃H₂₇FN₄O₄; 442.48 PRAZIQUANTEL RBPL-P2100 55268-74-1 C19H24N2O2; 312.41 Praziquantel Impurity A (Praziquantel Related Compound A) RBPL-P2101 54761-87-4 C19H18N2O2; 306.36 PHENYLALANINE RBPL-P2200 150-30-1 C9H11NO2; 165.19 Phenylalanine Impurity C RBPL-P2201 60-18-4 Hydrochloride: 16870-43-2 C₉H₁₁NO₃; 181.19 QUETIAPINE RBPL-Q0100 111974-69-7 C₂₁H₂₅N₃O₂S; 383.51 Quetiapine Impurity S (Quetiapine S-oxide) RBPL-Q0101 329216-63-9 C21H25N3O3S; 399.51 Quetiapine Impurity F (II) RBPL-Q0102 848814-27-7 (FB) C21H27N3O3S; 401.52 Quetiapine Impurity D (Quetiapine Dimer) RBPL-Q0103 945668-94-0 C30H24N4S2; 504.67 Quetiapine Impurity J RBPL-Q0104 1356906-17-6 C25H33N3O4S;471.61 Quetiapine Impurity P (Quetiapine N-Ethyl) RBPL-Q0105 1011758-03-4 C19H21N3S; 323.46
  • 13.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 13 of 16    Quetiapine Impurity Q RBPL-Q0105 011758-03-4 C25H34N3O4S;472.62 Quetiapine Impurity H (Quetiapine N-Oxide) RBPL-Q0106 1076199-40-0 C₂₁H₂₅N₃O₃S; 399.51 Quetiapine Impurity I (Desethoxy Quetiapine) RBPL-Q0107 329216-67-3 (base); 329218-14-6 (2HCl) C19H21N3OS; 339.45 Quetiapine Impurity N (Quetiapine S,N-Oxide) RBPL-Q0108 1800291-86-4 C₂₉H₄₁N₅O₃S ; 539.73 Quetiapine Impurity R RBPL-Q0109 2459-05-4 C₆H₈O₄; 144.13 Quetiapine Impurity G (Quetiapine Related Compound G) RBPL-Q0110 3159-07-7 C₁₃H₉NOS; 227.28 QUINAPRIL RBPL-Q0200 85441-61-8 C25H30N2O5; 438.47 Quinapril Impurity C (Quinapril Related Compound B) RBPL-Q0201 82768-85-2 C₂₃H₂₆N₂O₅; 410.46 QUINIDINE SULPHATE RBPL-Q0300 6591-63-5 C40H48N4O4 · H2O4S · 2H2O 782.94 Quinidine Sulfate Dihydrate (Quinine Sulfate Impurity A) RBPL-Q0301 6591-63-5 C40H48N4O4 · H2O4S · 2H2O; 782.94 ROXITHROMYCIN RBPL-R0100 80214-83-1 C41H76N2O15; 837.05 N,N-didesmethyl Roxithromycin RBPL-R0101 231620-65-8 C39H72N2O15; 809 Roxithromycin Impurity F (N-Desmethyl Roxithromycin) (Roxithromycin Related Compound F) RBPL-R0102 118267-18-8 C40H74N2O15; 823.02 Roxithromycin Impurity B RBPL-R0103 214902-82-6 C₃₃H₆₂N₂O₁₂; 678.85 Roxithromycin N-Oxide RBPL-R0105 1460313-73-8 C41H76N2O16; 853.06 Roxithromycin Impurity C (Erythromycin 9-Oxime Impurity) (Clarithromycin Impurity J) (Azithromycin Impurity S) RBPL-R0106 13127-18-9 C₃₇H₆₈N₂O₁₃; 748.94 RABEPRAZOLE RBPL-R0200 117976-89-3 C18H21N3O3S, 359.44 Rabeprazole Impurity I (Rabeprazole Sulfone N-Oxide) RBPL-R0201 924663-37-6 C18H21N3O5S; 391.44 Rabeprazole Impurity A (Rabeprazole Sulphone) (Rabeprazole Related Compound D) RBPL-R0202 117976-47-3 C18H21N3O4S; 375.44 Rabeprazole Impurity B (Rabeprazole Sulfide) (Rabeprazole Related Compound E) RBPL-R0203 117977-21-6 C₁₈H₂₁N₃O₂S; 343.44 Rabeprazole Impurity F (Rabeprazole Related Compound C) (Lansoprazole Impurity E) RBPL-R0205 583-39-1 C₇H₆N₂S; 150.2 RAMIPRIL RBPL-R0300 87333-19-5 C23H32N2O5. 416.51 Ramipril Impurity D (Ramipril Related Compound D) RBPL-R0301 108731-95-9 C23H30N2O4; 398.5 Ramipril Impurity B (Ramipril Related Compound B) RBPL-R0302 295328-72-2 C₂₄H₃₄N₂O₅; 430.54 Ramipril Impurity A (Ramipril Related Compound A) (Ramipril Methyl Ester) RBPL-R0306 108313-11-7 C22H30N2O5;402.49 RISPERIDONE RBPL-R0400 106266-06-2 C23H27FN4O2; 410.48 Risperidone Impurity C (9-OH Risperidone) RBPL-R0401 144598-75-4 C23H27FN4O3; 426.48 Risperidone-N-oxide (Risperidone Cis) RBPL-R0402 832747-55-4 C23H27FN4O3; 426.48 Risperidone Impurity E RBPL-R0403 1346602-28-5 C₂₄H₂₉FN₄O₂; 424.51 Risperidone-N-oxide (Trans) RBPL-R0404 NA C23H27FN4O3; 426.48 RANITIDINE RBPL-R0500 66357-35-5 C13H22N4O3S, 314.41 Ranitidine Impurity B RBPL-R0501 66356-53-4 C10H18N2OS; 214.33 Ranitidine-N-oxide RBPL-R0502 73857-20-2 C₁₃H₂₂N₄O₄S; 330.4 ROSUVASTATIN Calcium RBPL-R0700 147098-20-2 C22H27FN3O6S·½Ca; 500.57 Rosuvastatin lactone (Rosuvastatin Impurity-D) RBPL-R0701 503610-43-3 C₂₂H₂₆FN₃O₅; 463.52 RALOXIFENE RBPL-R0800 84449-90-1 C28H27NO4S, 473.58 Raloxifene Related Compound C (Raloxifene N-Oxide) RBPL-R0801 195454-31-0 C₂₈H₂₇NO₅S; 489.58 RANOLAZINE RBPL-R0900 95635-55-5 C24H33N3O4; 427.54 Ranolazine-N-oxide (Impurity 11) RBPL-R0901 NA C24H33N3O5; 443.55 Ranolazine-Bis N-oxide RBPL-R0902 1246816-00-1 C₂₄H₃₃N₃O₆; 459.54 RIZATRIPTAN RBPL-R1000 145202-66-0 C22H25N5O2, 391.47 Rizatriptan N-Oxide (Rizatriptan Impurity H) RBPL-R1001 260435-42-5 C15H19N5O; 285.35 SILDENAFIL RBPL-S0100 171599-83-0 C22H30N6O4S; 474.6 N-desmethyl Sildenafil RBPL-S0101 139755-82-1 C21H28N6O4S; 460.58 Sildenafil Impurity B (Sildenafil N-oxide) RBPL-S0102 1094598-75-0 C22H30N6O5S; 490.58 Sildenafil Impurity D RBPL-S0103 1357931-55-5 C17H20N4O5S ; 392.43 SOLIFENACIN RBPL-S0200 242478-38-2 C23H26N2O2; 362.473
  • 14.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 14 of 16    Solifenacin Impurity I (Solifenacin N-oxide) RBPL-S0201 180272-28-0 C₂₃H₂₆N₂O₃; 378.46 Solifenacin Impurity A RBPL-S0202 118864-75-8 C₁₅H₁₅N ; 209.29 Solifenacin Impurity E RBPL-S0203 25333-42-0 C7H13NO; 127.19 SERTRALINE RBPL-S0300 79617-96-2 C17H17Cl2N ; 306.23 Sertraline Impurity B (Sertraline Impurity-3) RBPL-S0302 52758-05-1 C17H20ClN; 273.80 Sertraline Impurity D (Sertraline Impurity-1) RBPL-S0304 871838-58-3 C17H18ClN ; 271.78 Sertraline Impurity C (Sertraline Impurity-2) RBPL-S0307 79646-00-7 C17H19ClN; 271.78 SULFASALAZINE RBPL-S0400 599-79-1 C18H14N4O5S; 398.394 Sulfasalazine Impurity D RBPL-S0401 66364-70-3 C17H14N4O3S; 354.38306 SIMVASTATIN RBPL-S0600 79902-63-9 C25H38O5; 418.56 Simvastatin Impurity C (Anhydro Simvastatin) RBPL-S0602 210980-68-0 C25H36O4; 400.56 Simvastatin Impurity F (Epi Lovastatin) RBPL-S0603 79952-44-6 C₂₄H₃₆O₅; 404.54 Simvastatin Impurity A (Simvastatin Related Compound A) (Simvastatin Hydroxy Acid) RBPL-S0604 530112-57-3 C50H80CaO13; 929.26 SUMATRIPTAN RBPL-S0800 103628-46-2 C14H21N3O2S; 295.402 Sumatriptan N-oxide (Sumatriptan Impurity D) RBPL-S0801 212069-94-8 C₁₄H₂₁N₃O₃S; 311.4 SITAGLIPTIN RBPL-S0900 486460-32-6 C16H15F6N5O, 407.31 Sitagliptin Impurity A RBPL-S0901 823817-58-9 C₁₆H₁5F₆N₅O; 407.32 Sitagliptin Impurity B RBPL-S0902 1345822-87-8 C₁₆H16F₅N₅O; 389.33 Sitagliptin Impurity C RBPL-S0903 1345822-86-7 C₁₆H₁6F₅N₅O; 389.31 Sitagliptin fumarate adduct (Sitagliptin Impurity-A) RBPL-S0904 2088771-60-0 C20H19F6N5O5 ; 523.39 SORAFENIB RBPL-S1000 284461-73-0 C21H16ClF3N4O3; 464.82 Sorafenib N-Oxide RBPL-S1001 583840-03-3 C21H16ClF3N4O; 480.82 SULFAMETHOXAZOLE RBPL-S1400 723-46-6 C10H11N3O3S; 253.28 Sulfamethoxazole Impurity F RBPL-S1401 17103-52-5 C10H11N3O3S; 253.28 SODIUM STEARYL RBPL-S1500 4070-80-8 C22H39NaO4; 390.54 Sodium Stearyl Fumarate SSF 4070-80-8 C22H39NaO4; 390.54 Sodium Stearyl Maleate SSM 5373-51-3 C22H39NaO4; 390.53 Monostearyl Maleate MSM 2424-62-2 C22H40O4; 368.55 SULINDAC RBPL-S1600 Sulindac Methyl Ester RBPL-S1603 134439-52-4 C21H19FO3S; 370.44 Sulindac Ethyl Ester RBPL-S1604 68299-97-8 C22H21FO3S; 384.46 Sulindac Isopropyl Ester RBPL-S1605 NA C23H23FO3S; 398.49 SULFADIAZINE RBPL-S1700 68-35-9 C10H10N4O2S; 250.28 SULFAQUINOXALINE SODIUM RBPL-S1800 967-80-6 C14H11N4NaO2S322.32 TELMISARTAN RBPL-T0100 144701-48-4 C33H30N4O2 514.62 Telmisartan Impurity F RBPL-T0101 915124-86-6 C₃₃H₃₁N₅O; 513.63 Telmisatran Impurity A (Telmisatran Related Compound A) RBPL-T0102 152628-02-9 C₁₉H₂₀N₄; 304.39 Telmisatran Impurity D RBPL-T0103 NA C26H24N2O4; 428.29 Telmisartan Methyl Ester RBPL-T0104 528560-93-2 C34H32N4O2 ; 528.6 Telmisartan Impurity B (Telmisatran Related Compound B) RBPL-T0105 1026353-20-7 C33H30N4O2; 514.62 TRAMADOL RBPL-T0200 27203-92-5 C16H25NO2; 263.38 Tramadol-N-oxide RBPL-T0201 147441-56-3 C16H25NO3; 279.37 Tramadol Impurity A (Tramadol Related Compound A) RBPL-T0202 2914-77-2; 152538-36-8 (FB); 73806-49-2 C16 H25NO2.ClH; 299.84 Tramadol Impurity D RBPL-T0203 NA; 185453-02-5 HCl; 80456-81-1 (FB) C15H23NO2.HCl; 249.36 ; 285.82 HCl Tramadol Impurity C RBPL-T0204 66170-31-8; 905592-54-3 (FB) C16H23NO; 245.37 Tramadol Impurity E (Tramadol Related Compound B) RBPL-T0205 42036-65-7 C9H18ClNO THIOCHOLCHICOSIDE RBPL-T0300 602-41-5 C27H33NO10S; 563.62 N-deacetyl-N-formyl Thiocholchicoside RBPL-T0302 219547-29-2 C26H31NO10S; 549.59 N-deacetyl-3-demethyl Thiocholchicine RBPL-T0303 97043-09-9 C19H21NO4S; 359.44 3-o-desmethyl Thiocholchicocine (Impurity C) RBPL-T0305 87424-25-7 C₂1H23NO5S; 401.48
  • 15.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 15 of 16    TROSPIUM RBPL-T0400 10405-02-4 C25H30ClNO3; 427.96 Trospium chloride Related Compound A (Trospium Impurity A) RBPL-T0401 76-93-7 C14H12O3; 228.24 Trospium Impurity D RBPL-T0402 467-32-3 C28H20O4; 420.45 TIMOLOL RBPL-T0600 26839-75-8 C13H24N4O3S; 316.421 Timolol Impurity D (Timolol Related Compound D) RBPL-T0601 30165-97-0 C6H9N3O2S; 187.22 Timolol Impurity B (Timolol Related Compound B) RBPL-T0602 158636-96-5 C13H24N4O3S; 316.43 Timolol Impurity A (Timolol Related Compound A) RBPL-T0603 26839-76-9 C13H24N4O3S; 316.42 TOLTERODINE RBPL-T0700 124937-51-5 C22H31NO; 325.49 Tolterodine Lactone RBPL-T0701 40546-94-9 C₁₆H₁₄O₂; 238.28 TAMSULOSIN RBPL-T0800 106133-20-4 C20H28N2O5S; 408.5117 Tamsulosin Impurity D RBPL-T0801 80223-96-7 C19H26N2O5S ; 394.49 Tamsulosin HCl Impurity G RBPL-T0802 80223-99-0; 106463-19-8 C₂₀H₂₉ClN₂O₅S; 444.97 Tamsulosin Impurity H RBPL-T0803 1329611-47-3 C20H27NO3; 329.43 Tamsulosin Impurity A RBPL-T0804 918867-88-6 C₃₀H₄₀N₂O₇S; 572.71 Tamsulosin Impurity B RBPL-T0805 112101-81-2 C10H16N2O3S; 244.31 Tamsulosin Impurity C RBPL-T0806 NA C18H24N2O4S.HCl; 364.45 36.5 TAMOXIFEN RBPL-T0900 10540-29-1 C26H29NO; 371.52 Tamoxifen-N-oxide RBPL-T0901 75504-34-6 C26H29NO2; 387.51 N-Desmethyl Tamoxifen Hcl RBPL-T0902 31750-48-8 C25H27NO; 357.49 TIZANIDINE RBPL-T1400 51322-75-9 C9H8ClN5S 253.71 Tizanidine Impurity A RBPL-T1401 51322-69-1 C9H9N5S; 219.27 Tizanidine Impurity B RBPL-T1402 51323-05-8 C₇H₅ClN₄S₂; 244.72 Tizanidine Impurity C RBPL-T1403 1147548-83-1 C16H14Cl2N10S2; 481.39 Tizanidine Impurity D RBPL-T1404 51323-03-6 C8H7CIN4S2; 258.75 Tizanidine Impurity E (Tizanidine Related Compound A) RBPL-T1405 30536-19-7 C6H4ClN3S; 185.63 Tizanidine Impurity F RBPL-T1406 1147548-85-3 C₁₆H₁₁Cl₂N₉S₂; 464.35 TRANEXAMIC ACID RBPL-T1500 Tranexamic acid RBPL-T1500 1197-18-8 C8H15NO2;157.21 Tranexamic acid Impurity D RBPL-T1501 56-91-7 C8H9NO2;151.16 TERBUTALINE RBPL-T1600 Terbutaline Sulphate Impurity C RBPL-T1601 139508-58-0 (Free base) 1246815-70-2 (HCl salt) C₁₂H₁₈ClNO₃; 259.73 TOFACITINIB RBPL-T1800 477600-75-2 C16H20N6O; 312.38 Tofacitinib pyrimidine N-oxide RBPL-T1801 2028267-73-2 C16H20N6O2 328.38 Tofacitinib pyrimidine N-oxide (Impurity 2) RBPL-T1802 NA C16H20N6O2 ; 328.37 TAPENTADOL RBPL-T2200 175591-09-0 C14H23NO·HCl; 257.80 Tapentadol N-Oxide RBPL-T2201 1346601-17-9 C14H23NO2; 237.34 TRIMETHOPRIM RBPL-T2400 738-70-5 C14H18N4O3; 290.32 Trimethoprim N-Oxide RBPL-T2401 27653-67-4 C14H18N4O;4 306.31 Trimethoprim N-Oxide RBPL-T2402 27653-68-5 C14H18N4O4; 306.32 Trimethoprim N,N-di-N-Oxide RBPL-T2403 TETRACYCLINE RBPL-T2500 60-54-8 C22H24N2O8; 444.43 Tetracycline Impurity D (4-Epianhydrotetracycline hydrochloride) RBPL-T2501 4465-65-0 C₂₂H₂₃ClN₂O₇;462.88 TIOTROPIUM RBPL-T2600 136310-93-5 C19H22BrNO4S2; 472.42 Tiotropium bromide Impurity G RBPL-T2601 1508-46-9 C9H16NBrO2; 250.13 THEOBROMINE RBPL-T2700 83-67-0 C7H8N4O2; 180.16 VERAPAMIL RBPL-V0100 52-53-9 C27H38N2O4; 454.602 Verapamil Impurity K RBPL-V0102 20850-49-1 C13H17NO2; 219.29 VENLAFAXINE RBPL-V0200 93413-69-5 C17H27NO2. 277.40 Desvenlafaxine succinate (O-Desmethyl Venlafaxine) RBPL-V0201 93413-62-8; 386750-22-7 C₁₆H₂₅NO₂; 263.38 Venlafaxine Impurity F RBPL-V0202 93413-79-7(Hcl) 93413-57-1(FB) C17H26ClNO; 295.85(Hcl) 259.4(FB)
  • 16.   REFSYN BIOSCIENCES PRIVATE LIMITED  PUDUCHERRY  Refsyn In‐stock API Impurities List (2021‐2022)  COMPOUND NAME PRODUCT CODE CAS NO. MF/MW Page 16 of 16    Venlafaxine Impurity B RBPL-V0203 323176-93-8 (base) C14H21NO3 (base); 251.32 Venlafaxine N-oxide RBPL-V0204 1021933-95-8 C₁₆H₂₅NO₃; 279.37 VALSARTAN RBPL-V0300 137862-53-4 C24H29N5O3; 435.52 Valsartan Methyl ester (Valsartan Related Compound E) RBPL-V0301 137863-17-3 C₂₅H₃₁N₅O₃; 449.55 Valsartan Isopropyl ester RBPL-V0302 1245820-09-0 C₂₇H₃₅N₅O₃; 477.6 Valsartan Ethyl ester RBPL-V0303 1111177-30-0 C₂₆H₃₃N₅O₃; 463.57 Valsartan Impurity C (Valsartan Related Compound B) RBPL-V0305 952652-79-8 C23H27N5O3; 421.49 VALPROIC ACID RBPL-V0400 1069-66-5Free acid: 99-66-1 C₈H₁₅NaO₂; 166.19 Valproic acid Related Compound A RBPL-V0403 99-67-2 C8H12O2 ; 140.18 VARDENAFIL RBPL-V0800 224785-90-4 C23H32N6O4S; 488.6 Vardenafil N-Oxide (Vardenafil Related Compound D) RBPL-V0801 448184-48-3 C₂₃H₃₂N₆O₅S; 504.6 VILDAGLIPTIN RBPL-V0900 274901-16-5 C17H25N3O2; 303.40 Vildagliptin Amide RBPL-V0902 565453-39-6 C₁₇H₂₇N₃O₃; 321.41 ZIDOVUDINE RBPL-Z0100 30516-87-1 C10H13N5O4; 267.24 Zidovudine Impurity B (Zidovudine Related Compound B) RBPL-Z0101 25526-94-7 C10H13ClN2O4; 260.67 ZIPRASIDONE RBPL-Z0200 146939-27-7 C21H21ClN4OS; 412.94 Ziprasidone Related Compound B RBPL-Z0201 1159977-56-6 C₂₁H₁₉ClN₄O₂S; 426.92 Ziprasidone Impurity E (Ziprasidone Related Compound D) RBPL-Z0202 1159977-04-4 C₂₈H₂₄ClN₅OS₂;546.11 Ziprasidone Impurity C (Ziprasidone Related Compound F) (Open Ring) RBPL-Z0203 1159977-64-6 C21H23ClN4O2S; 430.95 Ziprasidone Deschloro Impurity RBPL-Z0204 118305-72-9 C21H22N4OS; 378.5 Ziprasidone N-Oxide RBPL-Z0205 188797-76-4 C₂₁H₂₁ClN₄O₂S; 428.94 Ziprasidone S-Oxide RBPL-Z0206 188797-80-0 C₂₁H₂₁ClN₄O₂S; 428.94